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Executive Summary
The Massachusetts demonstration under the Financial Alignment Initiative will contract
with Medicare-Medicaid Plans (MMPs, hereafter referred to as One Care plans) to provide all
Medicare and Medicaid services to full-benefit Medicare-Medicaid enrollees aged 21 to 64. The
Centers for Medicare & Medicaid Services (CMS) and the Commonwealth of Massachusetts
have established a Federal-State partnership to implement the demonstration, which includes a
three-way contract between CMS, the Commonwealth, and participating One Care plans based
on a capitated model of financing. Individuals enrolled in 1915(c) waivers for home and
community-based services (HCBS) and a small number of individuals residing in an intermediate
care facility for individuals with intellectual disabilities (ICF/IID) are not eligible to enroll in the
demonstration. Benefits under the demonstration will be expanded to include services not
previously available to the eligible population, including diversionary behavioral health services,
community support services, and enhancements to existing State Plan services. The
demonstration will operate in counties where at least one plan proposed coverage and passed the
CMS/Commonwealth readiness review (CMS and Commonwealth of Massachusetts, 2012;
hereafter, Memorandum of Understanding [MOU], 2012). These counties will be Essex,
Franklin, Hampden, Hampshire, Middlesex, Norfolk, Plymouth (partial county), Suffolk, and
Worcester. The demonstration began on October 1, 2013, and will continue until December 31,
2016 (CMS communication, 5/29/13).
CMS contracted with RTI International to monitor the implementation of all State
demonstrations under the Financial Alignment Initiative, and to evaluate their impact on
beneficiary experience, quality, utilization, and cost. The evaluation includes an aggregate
evaluation and State-specific evaluations. This report describes the State-specific Evaluation
Plan for the Massachusetts demonstration as of December 16, 2013. The evaluation activities
may be revised if modifications are made to either the Massachusetts demonstration or to the
activities described in the Aggregate Evaluation Plan (Walsh et al., 2013). Although this
document will not be revised to address all changes that may occur, the annual and final
evaluation reports will note areas where the evaluation as executed differs from this evaluation
plan.
The goals of the evaluation are to monitor demonstration implementation, evaluate the
impact of the demonstration on the beneficiary experience, monitor unintended consequences,
and monitor and evaluate the demonstration’s impact on a range of outcomes for the eligible
population as a whole and for subpopulations (e.g., people with mental illness and/or substance
use disorders and long-term services and supports (LTSS) recipients). To achieve these goals,
RTI International will collect qualitative and quantitative data from Massachusetts each quarter;
analyze Medicare and Medicaid enrollment and claims data; conduct site visits, beneficiary focus
groups, and key informant interviews; and incorporate relevant findings from any beneficiary
surveys conducted by other entities. Information from monitoring and evaluation activities will
be reported in a 6-month initial implementation report to CMS and the Commonwealth, quarterly
monitoring reports provided to CMS and the Commonwealth, annual reports and a final
evaluation report. The key research questions and data sources for each are summarized in
Table ES-1.
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Table ES-1
Research questions and data sources

Research questions
1) What are the primary design features of the
Massachusetts demonstration, and how do they differ
from the Commonwealth’s previous system?
2) To what extent did Massachusetts implement the
demonstration as designed? What factors contributed to
successful implementation? What were the barriers to
implementation?
3) What impact does the Massachusetts demonstration
have on the beneficiary experience overall and for
beneficiary subgroups? Do beneficiaries perceive
improvements in how they seek care, choice of care
options, how care is delivered, personal health outcomes,
and quality of life?
4) What impact does the Massachusetts demonstration
have on cost and is there evidence of cost savings in the
Commonwealth? How long did it take to observe cost
savings in the Commonwealth? How were these savings
achieved in the Commonwealth?
5) What impact does the Massachusetts demonstration
have on utilization patterns in acute, long-term, and
behavioral health services, overall and for beneficiary
subgroups?
6) What impact does the Massachusetts demonstration
have on health care quality overall and for beneficiary
subgroups?
7) Does the Massachusetts demonstration change access
to care for medical, behavioral health, long-term services
and supports (LTSS) overall and for beneficiary
subgroups? If so, how?
8) What policies, procedures, or practices implemented
by Massachusetts in its demonstration can inform
adaptation or replication by other States?
9) What strategies used or challenges encountered by
Massachusetts in its demonstration can inform adaptation
or replication by other States?

Stakeholder
interviews and
site visits

Beneficiary
focus
groups

Claims and
Demonstration
encounter
data analysis
statistics1

X

X

—

X

X

—

—

X

X

X

—

X

—

—

X

—

X

X

X

X

—

—

X

X

X

X

X

X

X

X

—

X

X

X

—

X

— = not applicable.
1

Demonstration statistics refer to data that the Commonwealth, CMS, or other entities will provide regarding topics, including
enrollments, disenrollments, grievances, appeals, and the number of One Care plans.

The principal focus of the evaluation will be at the State level. CMS has engaged an
operations support contractor to monitor fulfillment of the demonstration requirements outlined
in the MOU and three-way contracts, including One Care plan (or MMP)-level monitoring. RTI
will integrate that information into the evaluation as appropriate.
Demonstration Implementation. Evaluation of demonstration implementation will be
based on case study methods and quantitative data analysis of enrollment patterns. We will
monitor progress, revisions to the demonstration, and identify transferable lessons from the
Massachusetts demonstration through the following: document review, ongoing submissions by
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the Commonwealth through an online State Data Reporting System (e.g., enrollment and
disenrollment statistics and qualitative updates on key aspects of implementation), quarterly key
informant telephone interviews, and at least two sets of site visits. We will also monitor and
evaluate several demonstration design features, including the Commonwealth’s progress
developing an integrated delivery system, integrated delivery system supports, care
coordination/case management, benefits and services, enrollment and access to care, beneficiary
engagement and protections, financing, and payment elements. Table 6 in Section 3 of this
report provides a list of the implementation tracking elements that we will monitor for each
design feature. Examples of tracking elements include State efforts to build plan and provider
core competencies for serving beneficiaries with various disability types; State requirements for
coordination and integration of clinical, LTSS, and behavioral health services; documentation of
coordination activities between One Care plans and community-based organizations; phase-in of
new or enhanced benefits, and methods to communicate them to eligible populations; and
strategies for expanding beneficiary access to demonstration benefits.
The data we gather about implementation will be used for within-State and aggregate
analyses, included in the 6-month implementation report to CMS and the Commonwealth and
annual reports, and will provide context for all aspects of the evaluation.
Beneficiary Experience. The impact of this demonstration on beneficiary experience is
an important focus of the evaluation. Our framework for evaluating beneficiary experience is
influenced by work conducted by the Center for Health Care Strategies (CHCS) on the elements
of integration that directly affect beneficiary experience for Medicare-Medicaid enrollees. Table
8 in Section 4 of this report aligns key elements identified in the CHCS framework with the
demonstration design features listed in the demonstration implementation section. The goals of
these analyses are to examine the beneficiary experience and how it varies by subpopulation, and
whether the demonstration has had the desired impact on beneficiary outcomes, including quality
of life.
To understand beneficiary experience, we will monitor Commonwealth-reported data
quarterly (e.g., reports of beneficiary engagement activities), and discuss issues related to the
beneficiary experience during quarterly telephone follow-up calls and site visits with the
Commonwealth and with stakeholders. We will also obtain data on grievances and appeals from
CMS and, as available, other sources. Focus groups will include Medicare-Medicaid enrollees
from a variety of subpopulations, such as people with mental health conditions, substance use
disorders, LTSS needs, and multiple chronic conditions. Relevant demonstration statistics will be
monitored quarterly and quantitative and qualitative analyses of the beneficiary experience will
be included in annual State-specific reports and the final evaluation report.
Analysis Overview. Quality, utilization, access to care, and cost will be monitored and
evaluated using encounter, claims, and enrollment data for a 2-year predemonstration period and
during the course of the demonstration. The evaluation will use an intent-to-treat (ITT) approach
for the quantitative analyses, comparing the eligible population for the Commonwealth’s
demonstration with a similar population that is not affected by the demonstration (i.e., a
comparison group). Under the ITT framework, outcome analyses will include all beneficiaries
eligible for the demonstration in the demonstration area, including those who opt out, participate
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but then disenroll, and those who enroll but may not seek services, and a group of similar
individuals in the comparison group. This approach diminishes the potential for selection bias
and highlights the effect of the demonstration on all beneficiaries in the demonstration-eligible
population. RTI will compare the characteristics of those who enroll with those who are eligible
but do not enroll in the care model and conduct analyses to further explore demonstration effects
on demonstration enrollees, acknowledging that selection bias must be taken into account in
interpreting the results.
Identifying Demonstration and Comparison Groups. To identify the population eligible
for the demonstration, Massachusetts will submit demonstration evaluation (finder) files to RTI
on a quarterly basis. RTI will use this information to identify the characteristics of eligible
beneficiaries for the quantitative analysis. Section 4.2.2.1 of this report provides more detail on
the contents of the demonstration evaluation (finder) files.
Identifying the comparison group members will entail two steps: (1) selecting the
geographic area from which the comparison group will be drawn and (2) identifying the
individuals who will be included in the comparison group. Because most Massachusetts counties
and demonstration-eligible beneficiaries will be included in the demonstration area, RTI will
most likely identify a comparison group from out-of-State Metropolitan Statistical Areas
(MSAs). We will use cluster analysis to identify potential comparison States and areas that are
most similar to Massachusetts in regard to costs, care delivery arrangements, and State policy
affecting Medicare-Medicaid enrollees. We will also consider including the nondemonstration
Massachusetts counties in the comparison group, together with the out-of-State areas. If the
Massachusetts demonstration is implemented in fewer counties than anticipated, we will consider
whether we can identify a comparison group that draws beneficiaries from nondemonstration
areas within the Commonwealth or from out of State that are similar to the demonstration areas.
Once a comparison area is selected, all Medicare-Medicaid enrollees in those States or
areas who meet the demonstration’s eligibility criteria will be selected for comparison group
membership based on the intent-to-treat study design. The comparison group will be refreshed
annually to incorporate new entrants into the eligible population as new individuals become
eligible for the demonstration over time. We will use propensity-score weighting to adjust for
differences in individual-level characteristics between the treatment and comparison group
members, using beneficiary-level data (demographics, socioeconomic, health, and disability
status) and county-level data (health care market and local economic characteristics). We will
remove from the comparison group any beneficiaries with a propensity score lower than the
lowest score found in the demonstration group.
The comparison areas will be determined within the first year of implementation in order
to use the timeliest data available. The comparison group members will be determined
retrospectively at the end of each demonstration year, allowing us to include information on
individuals newly eligible or ineligible for the demonstration during that year.
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Analyses. Analyses of quality, utilization, and cost in the Massachusetts evaluation will
consist of the following:
1. A monitoring analysis to track quarterly changes in selected quality, utilization, and
cost measures over the course of the Massachusetts demonstration.
2. A descriptive analysis of quality, utilization, and cost measures with means and
comparisons for subgroups of interest, including comparison group results, for annual
reports. This analysis will focus on estimates for a broad range of quality, utilization,
and cost measures, as well as changes in these measures across years or subgroups of
interest within each year.
3. Multivariate difference-in-differences analyses of quality, utilization, and cost
measures using a comparison group.
4. A calculation of savings twice during the demonstration. RTI is developing the
methodology for evaluating savings for States implementing capitated model
demonstrations, which will include an analysis of spending by program (Medicaid,
Medicare Parts A & B services, Medicare Part D services).
Subpopulation Analyses. For the Massachusetts demonstration, individuals with end stage
renal disease (ESRD), people receiving behavioral health services, individuals with chronic
physical conditions, and people receiving LTSS (including individuals with developmental
disabilities in the community who are not in 1915(c) waivers) are subpopulations of interest for
this evaluation. For these subpopulations and others, we will evaluate the impact of the
demonstration on quality, utilization, and access to care for medical, LTSS, and behavioral
health services, and also examine qualitative data gathered through interviews, focus groups, and
surveys. Descriptive analyses for annual reports will present results on selected measures
stratified by subpopulations (e.g., those using and not using behavioral health services, LTSS).
Multivariate analyses performed for the final evaluation will account for differential effects for
subpopulations to understand whether quality, utilization, and cost are higher or lower for these
groups.
Utilization and Access to Care. Medicare, Medicaid, and One Care plan encounter data
will be used to evaluate changes in the levels and types of services used, ranging along a
continuum from institutional care to care provided at home (see Table 15 of this report for more
detail). We will also include a specific focus on mental health and substance use disorder
prevention and treatment services and community support services, which will be expanded
under the demonstration.
Quality. Across all demonstrations, RTI will evaluate a core quality measure set for
monitoring and evaluation purposes that are available through claims and encounter data. RTI
will obtain these data from CMS (see Table 16 of this report). We will supplement these core
measures with the following:
•

Additional quality measures specific to Massachusetts, which will be finalized within
the first 6 months of implementation.
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•

Quality of life, satisfaction, and access to care information derived from the
evaluation as discussed in Section 4.1 and Section 4.2.

•

HEDIS measures that One Care plans are required to submit, as outlined in the
Medicare-Medicaid Capitated Financial Alignment Model Reporting Requirements
(CMS, 2013).

•

Beneficiary surveys, such as HOS and CAHPS, that One Care plans are required to
report to CMS.

Cost. To determine annual total costs (overall and by payer), we will aggregate the
Medicare and Medicaid per member per month (PMPM) payments paid to the One Care plans
and the costs for the eligible population that is not enrolled in the demonstration, per the intentto-treat evaluation design. This approach will help us to detect overall cost impact and eliminate
the effects of potential selection bias among beneficiaries who participate in the demonstration
and those who opt out or disenroll. We will also include Part D PMPM and any PMPM
reconciliation data provided by CMS in the final assessment of cost impact to ensure that all data
are available. Cost savings will be calculated twice for capitated model demonstrations using a
regression-based approach. The methodology for determining cost savings for capitated model
demonstrations is currently under development and will be reviewed and approved by the CMS
Office of the Actuary.
Summary of Data Sources. Table ES-2 displays the sources of information the RTI
evaluation team will use to monitor demonstration progress and evaluate the outcomes of the
Financial Alignment Demonstrations. The table provides an overview of the data that
Massachusetts will be asked to provide and evaluation activities in which State staff will
participate. As shown in this table, the evaluation team will access claims, encounter, and other
administrative data from CMS. These data, and how they will be used in the evaluation, are
discussed in detail in this evaluation plan and in the Aggregate Evaluation Plan (Walsh et al.,
2013).
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Table ES-2
Sources of information for the evaluation of the Financial Alignment Demonstrations
RTI will
obtain data
from:

Type of data

CMS

●
●
●
●
●
●
●
●

State

● Detailed description of State’s method for identifying eligible beneficiaries
● File with monthly information identifying beneficiaries eligible for the demonstration

Encounter data (Medicare Advantage, Medicaid, and One Care plans)
HEDIS measures
Results from HOS and CAHPS surveys
Medicare and Medicaid fee-for-service claims
Medicare Part D costs
Nursing Home data (MDS)
CMS-HCC and RXHCC risk scores
Demonstration quality measures that States are required to report to CMS (listed in
MOU)
● Demonstration quality measures that health plans are required to report to CMS (listed
in three-way contracts or other guidance)
● Other administrative data as available

●

●
●
●

(can be submitted monthly or quarterly)1
SDRS (described in detail in Section 4 of the Aggregate Evaluation Plan) quarterly
submissions of demonstration updates including monthly statistics on enrollments,
opt-outs, and disenrollments
Participation in key informant interviews and site visits conducted by RTI team
Results from surveys, focus groups, or other evaluation activities (e.g., EQRO or
Ombuds reports) conducted or contracted by the State,2 if applicable
Other data State believes would benefit this evaluation, if applicable

Other sources ● Results of focus groups conducted by RTI subcontractor (The Henne Group)
● Grievances and appeals
● Other sources of data, as available
CAHPS = Consumer Assessment of Healthcare Providers and Systems; EQRO = external quality review
organization; HCC = hierarchical condition category; HEDIS = Healthcare Effectiveness Data and Information Set;
HOS = Health Outcomes Survey; MDS = Minimum Data Set; MMP = Medicare Medicaid Plan; RXHCC =
prescription drug hierarchical condition category; SDRS = State Data Reporting System.
1

These data, which include both those enrolled and those eligible but not enrolled, will be used (in combination with
other data) to identify the characteristics of the total eligible and the enrolled population. More information is
provided in Section 4 of this report.
2
States are not required to conduct or contract for surveys or focus groups for the evaluation of this demonstration.
However, if the State chooses to do so, the State can provide any resulting reports from its own independent
evaluation activities for incorporation into this evaluation, as appropriate.
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1. Introduction
1.1

Purpose

The Medicare-Medicaid Coordination Office (MMCO) and Innovation Center at the
Centers for Medicare & Medicaid Services (CMS) have created the Financial Alignment
Demonstrations for States to test integrated care models for Medicare-Medicaid enrollees. The
goal of these Financial Alignment Demonstrations is to develop person-centered care delivery
models integrating the full range of medical, behavioral health, and long-term services for
Medicare-Medicaid enrollees, with the expectation that integrated delivery models would
address the current challenges associated with the lack of coordination of Medicare and
Medicaid benefits, financing, and incentives.
CMS contracted with RTI International to monitor the implementation of the
demonstrations and to evaluate their impact on quality, utilization, and cost. The evaluation
includes an aggregate evaluation and State-specific evaluations.
This report describes the State-specific Evaluation Plan for the Massachusetts
demonstration as of December 23, 2013. The evaluation activities may be revised if
modifications are made to either the Massachusetts demonstration or to the activities described in
the Aggregate Evaluation Plan (Walsh et al., 2013). Although this document will not be revised
to address all changes that may occur, the annual and final evaluation reports will note areas
where the evaluation as executed differs from this evaluation plan. This report provides an
overview of the Massachusetts demonstration and provides detailed information on the
framework for quantitative and qualitative data collection; the data sources, including data
collected through RTI’s State Data Reporting System (described in Section 3.5, Progress
Indicators, and in detail in the Aggregate Evaluation Plan [Walsh et al., 2013]); and impact and
outcome analysis (i.e., the impact on beneficiary experience and quality, utilization, access to
care, and costs) that will be tailored to Massachusetts.

1.2

Research Questions

The major research questions of the Massachusetts evaluation are presented in Table 1
with an identification of possible data sources. The evaluation will use multiple approaches and
data sources to address these questions. These are described in more detail in Sections 3 and 4 of
this report.
Unless otherwise referenced, the summary of the Massachusetts demonstration is based
on the Commonwealth’s proposal submitted to CMS on February 16, 2012 (Commonwealth of
Massachusetts, 2012a); the Commonwealth’s Memorandum of Understanding (MOU) with CMS
(CMS and Commonwealth of Massachusetts, 2012; hereafter, MOU, 2012); the Request for
Responses from Integrated Care Organizations (Commonwealth of Massachusetts and CMS,
2012c; hereafter, RFR, 2012); and an Addendum to the State Demonstration to Integrate Care for
Dual Eligible Individuals (Commonwealth of Massachusetts, 2012b; hereafter, Addendum, 2012.
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Table 1
Research questions and data sources

Research questions

Stakeholder
Beneficiary
interviews and
focus
site visits
groups

Claims and
encounter
Demonstration
data analysis
statistics1

1) What are the primary design features of the
Massachusetts demonstration, and how do they differ
from the Commonwealth’s previous system?

X

X

—

X

2) To what extent did Massachusetts implement the
demonstration as designed? What factors contributed to
successful implementation? What were the barriers to
implementation?

X

—

—

X

3) What impact does the Massachusetts demonstration
have on the beneficiary experience overall and for
beneficiary subgroups? Do beneficiaries perceive
improvements in how they seek care, choice of care
options, how care is delivered, personal health outcomes,
and quality of life?

X

X

—

X

4) What impact does the Massachusetts demonstration
have on cost and is there evidence of cost savings in the
Commonwealth? How long did it take to observe cost
savings in the Commonwealth? How were these savings
achieved in the Commonwealth?

—

—

X

—

5) What impact does the Massachusetts demonstration
have on utilization patterns in acute, long-term, and
behavioral health services, overall and for beneficiary
subgroups?

X

X

X

X

6) What impact does the Massachusetts demonstration
have on health care quality overall and for beneficiary
subgroups?

—

—

X

X

7) Does the Massachusetts demonstration change access
to care for medical, behavioral health, long-term services
and supports (LTSS) overall and for beneficiary
subgroups? If so, how?

X

X

X

X

8) What policies, procedures, or practices implemented
by Massachusetts in its demonstration can inform
adaptation or replication by other States?

X

X

—

X

9) What strategies used or challenges encountered by
Massachusetts in its demonstration can inform adaptation
or replication by other States?

X

X

—

X

N/A = not applicable.
Demonstration statistics refer to data that the Commonwealth, CMS, or other entities will provide regarding topics,
including enrollments, disenrollments, grievances, appeals, and the number of One Care plans.
1

The details of the evaluation design are covered in the three major sections that follow:
●

An overview of the Massachusetts demonstration

●

Demonstration implementation, evaluation and monitoring

●

Impact and outcome evaluation and monitoring.

Massachusetts Evaluation Design Plan — December 23, 2013

2

2. Massachusetts Demonstration
2.1

Demonstration Goals

The goals of the Massachusetts demonstration are “to alleviate the fragmentation and
improve coordination of services for Medicare-Medicaid Enrollees, enhance quality of care and
reduce costs for both the Commonwealth and the Federal government” (Memorandum of
Understanding [MOU], 2012, p. 2). Key objectives of the demonstration are “to improve the
beneficiary experience in accessing care, deliver person-centered care, promote independence in
the community, improve quality, eliminate cost shifting between Medicare and Medicaid and
achieve cost savings for the Commonwealth and Federal government through improvements in
care and coordination. CMS and the Commonwealth expect this model of integrated care and
financing to, among other things, improve quality of care and reduce health disparities, meet
both health and functional needs, and improve transitions among care settings. Meeting
beneficiary needs, including the ability to self-direct care, be involved in one’s care, and live
independently in the community, are central goals of this initiative” (MOU, 2012, p. 3).

2.2

Summary of Demonstration

Massachusetts and CMS have contracted with Medicare-Medicaid Plans (MMPs;
hereafter referred to as One Care plans), to provide Medicare and Medicaid services for fullbenefit Medicare-Medicaid enrollees aged 21 to 64 at the time of enrollment who are not
enrolled in Home and Community-Based Services (HCBS) waivers, are not residing in an
intermediate care facility for individuals with intellectual disabilities (ICF/IID), do not have
other comprehensive insurance, and meet other eligibility criteria as described in the MOU. The
demonstration will operate in counties in which at least one plan proposed coverage and passed
the CMS/Commonwealth readiness review (CMS and Commonwealth of Massachusetts, 2012;
hereafter, MOU, 2012). These counties will be Essex, Franklin, Hampden, Hampshire,
Middlesex, Norfolk, Plymouth (partial county), Suffolk, and Worcester. The demonstration
began on October 1, 2013, and will continue until December 31, 2016 (CMS communication,
5/29/13).
Benefits for individuals enrolled in the demonstration will include all Medicare and
Medicaid services, as well as services not previously available to these beneficiaries, including
diversionary behavioral health services (e.g., community crisis stabilization, partial
hospitalization, acute treatment and clinical support for substance abuse), community support
services (e.g., home care services, peer support/counseling/navigation, care transition assistance),
and enhancements to existing State Plan services (e.g., preventive, restorative, and emergency
oral health; cueing and supervision for personal care services) (MOU, 2012, pp. 69–81). “[One
Care plans] will offer care coordination services to all Enrollees through a Care Coordinator or
Clinical Care Manager, for medical and behavioral health services; and through an Independent
Living and Long-Term Services and Supports (IL-LTSS) Coordinator contracted from a
community-based organization, for LTSS. The IL-LTSS Coordinator [will] be a full member of
the Interdisciplinary Care Team as appropriate, serving at the discretion of the Enrollee” (MOU,
2012, p. 58).
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Beneficiaries will be offered a choice of One Care plans in their service area, or to opt out
of the demonstration. Those who do not select a One Care plan and do not opt out of the
demonstration may be passively enrolled in the demonstration and assigned to a One Care plan.
Prior to the effective date of passive enrollment, individuals will have a period of at least 60 days
to choose a different One Care plan or opt out of the demonstration.
To participate in the demonstration, One Care plans had to meet the Commonwealth’s
requirements set forth in the Massachusetts Request for Responses (RFR) (RFR, 2012); CMS
requirements outlined in capitated Financial Alignment Demonstration guidance; and pass a joint
CMS/Commonwealth readiness review. Both existing organizations and newly formed
organizations were eligible to apply to be One Care plans. Selected One Care plans will be
responsible for the delivery and management of all Medicaid, Medicare, and new and expanded
services for demonstration enrollees, with the exception of Targeted Case Management (TCM)
services provided by the Massachusetts Department of Mental Health (DMH) and the
Department of Developmental Services (DDS) or rehabilitation option services purchased by
DMH (MOU, 2012, p. 82). TCM and rehabilitation option services will not be included in the
capitated rate, and will continue to be provided on an FFS basis to demonstration enrollees.
Capitation payments to the One Care plans are described and agreed to in three-way
contracts among CMS, the Commonwealth, and participating One Care plans. The goal of the
integrated capitation payments is to test a new payment methodology that will minimize cost
shifting, align incentives between Medicare and Medicaid, and support the best possible
outcomes for enrollees (MOU, 2012, p. 3).
Table 2 provides a summary of the key characteristics of the Massachusetts
demonstration compared with the system that currently exists for demonstration-eligible
beneficiaries.
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Table 2
Key features of Massachusetts model predemonstration and during the demonstration
Key features
Summary of covered benefits
Medicare

Demonstration1

Predemonstration
Medicare Parts A, B, and D

Medicare Parts A, B, and D. Exclusions are listed
below.

Medicaid State Plan

Medicaid State Plan services, as well as new
diversionary behavioral health and community
support services, and expanded State Plan services
(e.g., dental, DME services). Exclusions are listed
below.

Mostly FFS; very small
percentage in Medicare
Advantage Plans or PACE

Capitated

FFS

Capitated. Medicare hospice services remain FFS
(as in Medicare Advantage).

Behavioral health

FFS

Capitated. Service exclusions: TCM for
beneficiaries with SPMI or developmental
disabilities and rehabilitation option services for
beneficiaries with SPMI are not included in the
capitation rate under the demonstration. The
Commonwealth continues to provide this service
on an FFS basis.

LTSS

FFS

Capitated. Individuals enrolled in 1915(c) HCBS
waivers and individuals residing in ICF/IIDs are
not eligible to enroll in the demonstration.

Not available to the eligible
population; some services
available via HCBS waivers
or managed care plans.

Capitated

No

Capitated

Medicaid

Payment method (capitated/
FFS/MFFS)
Medicare

Medicaid (capitated or FFS)
Primary/medical

Other (specify)
Diversionary behavioral
health services

Expanded services
including preventive,
restorative, and
emergency oral health
benefits; personal care
assistance that may be
hands on or cueing and
supervision)

(continued)
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Table 2 (continued)
Key features of Massachusetts model predemonstration and during the demonstration
Key features
Community Support
Services (day services,
home care services,
respite, peer support, care
transition assistance,
home modifications,
community health
workers, medication
management, nonmedical
transportation)

Demonstration1

Predemonstration
Not available to the eligible
population; some services
available via HCBS waivers
or managed care plans.

Capitated

Care coordination/case
management
Care coordination for medical, Medical homes provide some One Care plans will offer care coordination
behavioral health, or LTSS and care coordination for medical through a care coordinator or clinical care manager
by whom
and behavioral services.
for medical and behavioral health services; and
through an IL-LTSS coordinator, contracted from
a community-based organization, for LTSS.
Care coordination/case
management for HCBS
waivers and by whom

Case management of LTSS
via HCBS waivers operated
by Department of
Developmental Services
(DDS), The Massachusetts
Rehabilitation Commission
and the Executive Office of
Elder Services.2

People enrolled in HCBS waivers are not eligible
for the demonstration.

Targeted Case Management

Provided to certain
individuals served by DDS
and DMH.3

No change; TCM is not included in the capitation
rate under the demonstration. The Commonwealth
continues to provide this service on an FFS basis.
People receiving TCM are eligible to participate in
the demonstration.

Rehabilitation Option services

Provided through DMH
contractors to clients of
DMH.3

No change; Rehabilitation Option services are not
included as covered service in the capitation rate.
The Commonwealth continues to provide on an
FFS basis. People receiving Rehabilitation Option
services are eligible to participate in the
demonstration.

Clinical, integrated, or
intensive care management

None

Primary care provider, with One Care plan
support, will provide clinical care management for
individuals with multiple chronic conditions,
prescription drugs, or at high risk. Care
coordinators for enrollees with complex clinical
care needs will be clinical care managers.
(continued)
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Table 2 (continued)
Key features of Massachusetts model predemonstration and during the demonstration
Key features
Enrollment/assignment
Enrollment method

Demonstration1

Predemonstration
N/A

Attribution/assignment method N/A

Beneficiaries are offered a choice of One Care
plan, or to opt out of the demonstration and
remain in FFS (or join Medicare Advantage or
another program, if applicable). Those who do not
select a One Care plan and who do not opt out are
passively enrolled in the demonstration, and can
change One Care plans or opt out of the
demonstration on a monthly basis.
Beneficiaries who do not opt out or make an
affirmative choice of a One Care plan are autoassigned to a One Care plan.

Implementation
Geographic area

N/A

9 counties: Essex, Franklin, Hampden, Hampshire,
Middlesex, Norfolk, Plymouth (partial), Suffolk,
Worcester.

Phase-in plan

N/A

The first enrollment period will be opt-in only.
Beneficiaries will be offered the opportunity to
select a One Care plan or indicate that they will
opt out of the demonstration. First enrollments
will take effect no sooner than October 1, 2013.
Subsequently, there will be at least two passive
enrollment periods, with tentative effective
enrollment dates of January 1, 2014, and April 1,
2014, first.

Implementation date

N/A

The first effective enrollment date will be no
sooner than October 1, 2013, for beneficiaries who
opt into the demonstration.

DMH = Department of Mental Health; FFS = fee-for-service; HCBS = home and community-based services; ICF/IID =
intermediate care facility for individuals with intellectual disabilities; LTSS = long-term services and supports; MFFS = managed
fee for service; N/A = not applicable; SPMI – severe and persistent mental illness; TCM = targeted case management.
1

Information related to the Demonstration in this table is from the Memorandum of Understanding between Centers for Medicare
& Medicaid Services and the Commonwealth of Massachusetts; dated August 22, 2012 (MOU, 2012).
2
Commonwealth of Massachusetts, 2012b, p.1; hereafter, Addendum, 2012.
3
Addendum, 2012, p 3.

Individuals aged 21 through 64 at the time of enrollment who are enrolled in Medicare
Parts A and B and eligible for Medicare Part D, who are enrolled in MassHealth Standard (the
Massachusetts Medicaid program, operating under a §1115(a) waiver) or CommonHealth, 1 and
who have no other comprehensive private or public insurance will be eligible for enrollment in
this demonstration (MOU, 2012, p. 8). Beneficiaries who are enrolled in an HCBS waiver or
who are residents of an ICF/ID are not eligible to enroll in the demonstration, although the
1

CommonHealth is an expansion program for working and nonworking people with disabilities authorized through
the MassHealth §1115 demonstration.

Massachusetts Evaluation Design Plan — December 23, 2013

7

Measurement, Monitoring, and Evaluation of State
Demonstrations to Integrate Care for Dual Eligible Individuals

2. Massachusetts Demonstration

Commonwealth is considering phasing in the HCBS waiver enrollees later. Beneficiaries who
turn 65 while enrolled in the demonstration will be able to choose to remain in the
demonstration, return to FFS Medicare and Medicaid, join a Medicare Advantage plan or the
Program of All-inclusive Care for the Elderly (PACE), or participate in another program, if
applicable. Eligible beneficiaries who are enrolled in a Medicare Advantage or PACE plan,
Employer Group Waiver Plans (EGWP), other employer-sponsored plans, plans receiving a
Retiree Drug Subsidy, or individuals participating in the CMS Independence at Home
demonstration may enroll in the Financial Alignment Demonstration if they choose to disenroll
from their existing programs (MOU, 2012, p. 8).
Providers serving as Medicare Pioneer or Shared Savings Program Accountable Care
Organizations (ACOs) may contract with One Care plans as network providers and serve
Medicare-Medicaid enrollees under the Financial Alignment Demonstration, but these providers
will not be eligible to earn Medicare shared savings payments from CMS for beneficiaries who
are enrolled in the Financial Alignment Demonstration. Massachusetts encourages One Care
plans to enter into alternative payment arrangements with contracted providers, including
providers also serving as ACOs, that will advance the demonstration delivery system
innovations, incentivize quality care, and improve health outcomes for demonstration enrollees.
The characteristics of the population eligible to participate in the demonstration are
presented in Table 3. Approximately 98.5 percent of the eligible population resides in the
community and 1.5 percent of the individuals reside in a facility. Of those residing in the
community, approximately 41 percent of the individuals had a severe and persistent mental
illness and 34 percent had a substance use disorder. Fifty-six percent had a chronic physical
condition, and 8 percent had an intellectual disability. Of those residing in a facility, 60 percent
had a severe and persistent mental illness, 24 percent had a substance use disorder, 76 percent
had a chronic physical condition, and 10 percent had an intellectual disability 2 (Commonwealth
of Massachusetts, 2013).

2

Individuals can have more than one condition; thus the sum of the percentages for the characteristics of the
eligible population will be greater than 100 percent.
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Table 3
Characteristics of eligible population1 for December 2012
Condition

No. of beneficiaries

Population residing in a facility2
Severe and persistent mental illness3,4

1,608

Substance use condition3
Chronic physical condition
Intellectual disability

3,5

3

Population residing in the community
Severe and persistent mental illness3,4
Substance use condition

Percentage of eligible
population
1.5%

—

60%

—

24%

—

76%

—

10%

107,245

3

98.5%

—

41%

—

34%

Chronic physical condition3,5

—

56%

Intellectual disability3

—

8%

Total individuals potentially eligible for demonstration
(Medicare-Medicaid enrollees aged 21 to 64)

108,853

100.0%

— = not available.
1

Includes individuals 21–64 years old who are enrolled in Medicare Parts A and B, eligible for Medicare Part D,
receiving MassHealth Standard or CommonHealth, and have no other comprehensive coverage. These numbers
include beneficiaries throughout the Commonwealth, and are not limited to the counties served by One Care plans in
2013.
2
Facility residence includes individuals with extended episodes of care in any of the following: Intermediate Care
Facility, Skilled Nursing Facility, Chronic Disease Hospital, Psychiatric Hospital, or Rehabilitation Hospital.
3
Conditions based on Verisk Health’s DxCG Risk Solutions software. Individuals can have more than one
condition; thus the sum of the percentages for the characteristics of the eligible population will be greater than 100
percent.
4
Includes Schizophrenia, and Major Depressive, Bipolar and Paranoid Disorders.
5
Includes Asthma, Diabetes, COPD, CHF, Hypertension, Arthritis and Coronary Artery Disease.
SOURCE: Commonwealth of Massachusetts, Executive Office of Health and Human Services. Office of Medicaid.
Boston, MA (September 4, 2013).

Although Massachusetts will not include TCM services or Rehabilitation Option services
in the capitation rate, the people receiving those services will be eligible for the demonstration
(as long as they meet demonstration eligibility criteria). Their other services (e.g., medical, acute,
community LTSS) will be managed and paid for by the One Care plans, whereas TCM and
Rehabilitation Option services will continue to be purchased separately by the Commonwealth
agencies. Massachusetts stresses the importance of including people receiving these services in
the demonstration because they will be able to access the integrated diversionary behavioral
health services that are not available in the fee-for-service (FFS) system. Massachusetts indicated
that approximately 8,046 individuals (who were not on HCBS waivers) used TCM in 2009 and
used approximately $24.5 million in nonwaiver services. The same year, 2,565 Department of
Mental Health clients used approximately $37.5 million in services (including the Rehabilitation
Option and the TCM) (Addendum, 2012, p. 3).
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As shown in Table 4, the total Medicare and Medicaid spending on Medicare-Medicaid
enrollees aged 21 to 64 was $2.6 billion in CY 2008. This spending was roughly evenly divided
between the two programs. Total Medicare and Medicaid spending for those enrolled in HCBS
waivers (aged 18 to 64) was $569 million; as noted, this population will not be eligible for the
demonstration (not shown) (Massachusetts proposal, p. 6).
Table 4
Total expenditures for Medicare-Medicaid enrollees aged 21–64, CY 2008
Population
Eligible population

Medicaid
expenditures

Medicare
expenditures

Total
expenditures

$1.305 billion

$1.319 billion

$2.624 billion

NOTE: These numbers include beneficiaries throughout the Commonwealth, and are not limited to the counties
served by One Care plans in 2013.
SOURCE: Commonwealth of Massachusetts, Executive Office of Health and Human Services. Office of Medicaid:
State demonstration to integrate care for dual eligible individuals: Proposal to the Center for Medicare and Medicaid
Innovation. (Contract No. HHSM-500-2011-00033C). Boston, MA, Massachusetts Office of Health and Human
Services; February 16, 2012; pp. 5 and 6. These data include expenditures for HCBS Waiver enrollees.

2.3

Relevant Historical and Current Context

History/Experience with Managed Care. Massachusetts has extensive experience with
the design, implementation, and operation of managed care for Medicare-Medicaid enrollees and
Medicaid-only individuals. The Massachusetts demonstration builds on the Commonwealth’s
experience with two programs that serve Medicare-Medicaid enrollees: the PACE program and
the Senior Care Options (SCO) program. PACE programs first were implemented in
Massachusetts in 1990, and five such programs now serve individuals 55 or older. The SCO
program was implemented in 2004 and has enrolled more than 18,000 individuals aged 65 or
older. The PACE and SCO programs include comprehensive, integrated, managed care plans that
include all services covered by Medicare and MassHealth. The five SCO organizations in
Massachusetts operate “as Medicare Advantage duals special needs plans (D-SNPs) and as
Medicaid Managed Care plans” (Commonwealth of Massachusetts, 2012a).
Massachusetts also has experience with managed care for individuals who have only
Medicaid benefits. Under its §1115(a) demonstration, the Commonwealth operates a behavioral
health plan for MassHealth-only members who are enrolled in the Primary Care Clinician Plan
(PCCP), and the Commonwealth contracts with other managed care organizations for Medicaidonly members enrolled in managed care.
Other Initiatives. The Massachusetts demonstration is part of a larger health care reform
strategy to transform the Commonwealth’s health care system. Phase I of the reform began in
2006 with passage of a health care reform law to expand access to health care insurance,
resulting in coverage of 98 percent of the population by 2012 (Massachusetts Proposal, 2012b,
p. 20). The law also created the Health Care Quality and Cost Council, which is directed to
establish goals for improving health care quality, containing costs, and reducing racial and ethnic
disparities in health care; to demonstrate progress in meeting those goals; and to disseminate
comparative cost and quality information on its website. Phase II focuses on innovative delivery
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system and payment reforms designed to improve quality, expand access to care coordination,
enhance accountability, and reduce costs. The Commonwealth administration is promoting a
shift across all sectors of the health care system from fee-for-service payment to global
payments.
Several other initiatives in the Commonwealth are aligned with the goals of the
demonstration. These include the Patient-Centered Medical Home Initiative (PCMHI), the
development of Medicaid accountable care organizations, the implementation of the Money
Follows the Person (MFP) rebalancing demonstration, bundled payment pilots in MassHealth,
and exploration of Medicaid Health Homes.
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3. Demonstration Implementation Evaluation
3.1

Purpose

The evaluation of the implementation process is designed to answer the following
overarching questions about the Massachusetts demonstration:

3.2

•

What are the primary design features of the Massachusetts demonstration, and how
do they differ from the Commonwealth’s previous system available to the
demonstration eligible population?

•

To what extent did Massachusetts implement the demonstration as designed? What
factors contributed to successful implementation? What were the barriers to
implementation?

•

What Commonwealth policies, procedures, or practices implemented by
Massachusetts can inform adaptation or replication by other States?

•

Was the demonstration more easily implemented for certain subgroups?

•

How have beneficiaries participated in the ongoing implementation and monitoring of
the demonstration?

•

What strategies used or challenges encountered by Massachusetts can inform
adaptation or replication by other States?

Approach

The evaluation team will examine whether the demonstration was implemented as
designed and will look at modifications to the design features that were made during
implementation; any changes in the time frame or phase-in of the demonstration; and other
factors that facilitated or impeded implementation. This section will discuss the following:
•

Monitoring implementation of the demonstration by key demonstration design
features

•

Implementation tracking elements

•

Progress indicators

•

Data sources

•

Interview questions and implementation reports

Massachusetts Evaluation Design Plan — December 23, 2013

13

Measurement, Monitoring, and Evaluation of State
Demonstrations to Integrate Care for Dual Eligible Individuals

3.3

3. Demonstration Implementation Evaluation

Monitoring Implementation of the Demonstration by Key
Demonstration Design Features

The major design features of the Massachusetts demonstration are described using a
common framework that RTI will apply to all of the Financial Alignment demonstrations as
follows:
•

Integrated delivery system

•

Integrated delivery system supports

•

Care coordination/case management

•

Benefits and services

•

Enrollment and access to care

•

Beneficiary engagement and protections

•

Financing and payment

•

Payment elements

Our analysis of the implementation of the Massachusetts demonstration will be organized
by these key demonstration design features. This framework will be used to define our areas of
inquiry, structure the demonstration variables we track, organize information from our data
collection sources, and outline our annual report. Table 5 illustrates the key components of each
design feature that we will monitor as part of the implementation evaluation.
Table 5
Demonstration design features and key components
Design feature

Core components of integrated delivery
systems (how the delivery system is
organized/integrated; interrelationships
among the core delivery system
components)

Key components
●
●
●
●
●
●

One Care plans
Primary care, including medical homes
LTSS
Behavioral health services
Developmental disability services
Integration functions that bridge delivery systems and roles
of community-based organizations
(continued)
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Table 5 (continued)
Demonstration design features and key components
Design feature

Integrated delivery systems supports

Key components
● Care team composition
● Health IT applied throughout the demonstration (at

●

●

Care coordination/case management (by
subpopulation and/or for special services)
● Medical/primary
● LTSS
● Behavioral health services
● Integration of care coordination
Benefits and services

●
●
●
●
●

Enrollment and access to care

●
●
●
●
●
●
●
●
●

Beneficiary engagement and protections

●

●
●
●
●

●
●
●

Commonwealth level, by One Care plans, at provider level
or other)
Data (Medicare claims or encounter data) and other
feedback to One Care plans, medical homes, other providers
(by the Commonwealth or other entities)
Primary care practice support (e.g., coaching, learning
collaboratives, training)
Assessment process
Service planning process
Care management targeting process
Support of care transitions across settings
Communication and hand-offs between care coordinators/
case managers and providers
Scope of services/benefits
New or enhanced services
Excluded services
Service authorization process
Integrated enrollment and access
Provider accessibility standards
Marketing/education protocols
Enrollment brokers
Beneficiary information and options counseling
Opt-out, disenrollment, and auto-assignment policy
Assignment/referrals to providers and medical homes
Phased enrollment of eligible populations
Workforce development for worker supply and new
functions
Commonwealth policies to integrate Medicare and
Medicaid grievances and appeals
Quality management systems
Ongoing methods for engaging beneficiary organizations in
policy decisions and implementation
Approaches to capture beneficiary experience, such as
surveys and focus groups
(continued)
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Table 5 (continued)
Demonstration design features and key components
Design feature

Demonstration financing model and
methods of payment to plans and
providers

Key components
● Financing model—capitation
● Entities to which the Commonwealth is directly making
●

Elements of payments to One Care plans
and providers

●
●
●

payments
Innovative payment methods to One Care plans and/or to
providers
Incentives
Shared savings
Risk adjustment

IT = information technology; LTSS = long-term services and supports.

3.4

Implementation Tracking Elements

Through document review and interviews with Commonwealth agency staff, we will
identify and describe the delivery system for Medicare-Medicaid enrollees in the eligible
population. This will enable us to identify key elements that Massachusetts intends to modify
through the demonstration and measure the effects of those changes. Using a combination of
case study methods, including document review, and telephone interviews, we will conduct a
descriptive analysis of the Commonwealth’s key demonstration features.
The evaluation will analyze how Massachusetts is carrying out its implementation plan
and track any changes it makes to its initial design as implementation proceeds. We will identify
both planned changes that are part of the demonstration design (e.g., phasing in new populations)
and operational and policy modifications Massachusetts makes based on changing
circumstances. Finally, we anticipate that, in some instances, changes in the policy environment
in the Commonwealth will trigger alterations to the original demonstration design.
During site visit interviews and our ongoing communication with the Commonwealth, we
will collect detailed information on how Massachusetts has structured care coordination for
beneficiaries enrolled in the demonstration. The evaluation will analyze the scope of care
coordination responsibilities assigned to One Care plans, the extent to which they conduct these
functions directly or through contract, and internal structures established to promote service
integration. We will also identify ways that the scope of care coordination activities conducted
under the demonstration by One Care plans compares to the Commonwealth’s approach in their
capitated managed care programs serving other populations.
We will also collect data from the Commonwealth to track implementation through the
State Data Reporting System (SDRS). The Commonwealth will submit quarterly demonstration
statistics and qualitative updates through the SDRS (described in Section 3.5, Progress
Indicators, and in detail in the Aggregate Evaluation Plan [Walsh et al., 2013]). RTI will
generate reports based on these data and conduct telephone calls with the Commonwealth
demonstration director as needed to understand the Massachusetts entries. We will make
additional calls to Commonwealth agency staff and key informants as needed to keep abreast of
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demonstration developments. We will use site visit interviews to learn more about what factors
are facilitating or impeding progress or leading to revisions in the Massachusetts demonstration
implementation.
Table 6 shows the types of demonstration implementation elements we will track using
State submissions to the SDRS, quarterly calls with State demonstration staff, other interviews,
and site visits.
Table 6
Implementation tracking elements by demonstration design feature
Design feature

Integrated delivery system

Tracking elements
● Three-way contracts with One Care plans
● Documentation of coordination activities between One Care plans
●
●
●

Integrated delivery system
supports

●
●
●
●

●
●

●

Care coordination

●
●
●
●
●
●
●
●
●
●

and community-based organizations
New waiver authorities submitted for the demonstration and
approved
Emergence of new medical homes and health homes
Strategies for integrating primary care, behavioral health, and LTSS
(as documented in Commonwealth policies, contracts, or guidelines)
Recognition and payment for care/services by nontraditional workers
Innovative care delivery approaches adopted by the demonstration
Learning collaboratives of primary care providers
Support with dissemination and implementation of evidence-based
practice guidelines (e.g., webinars for providers; topics addressed in
learning collaboratives)
Decision-support tools provided or supported by the Commonwealth
Commonwealth efforts to build One Care plan and provider core
competencies for serving beneficiaries with various types of
disabilities
Provision of regular feedback to One Care plans and providers on the
results of their performance measures
Adoption of person-centered care coordination practices
Commonwealth or plan systems for collecting data on care
coordination use
As available, care coordination activities directed to individual
enrollees
Commonwealth requirements for assessment and care planning
Commonwealth requirements for coordination and integration of
clinical, LTSS, and behavioral health services
Commonwealth approaches to stratify care coordination intensity
based on individual needs
Commonwealth-level analyses of enrollee care transitions
Commonwealth requirements for care transition support, medication
reconciliation, notification of hospitalizations
Commonwealth actions to facilitate adoption of EMR and EHR
Use of informatics to identify high-risk beneficiaries
(continued)
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Table 6 (continued)
Tracking elements by demonstration design feature
Design feature

Benefits and services

Tracking elements
● Phase-in of new or enhanced benefits, and methods to communicate

them to enrollees and potential enrollees

● Adoption of evidence-based practices and services (e.g., use of

Enrollment and access to care

●
●

●
●
●

Beneficiary engagement and
protections

●
●
●
●

Financing and payment

●
●
●
●

chronic disease self-management programs, fall prevention
programs, other)
Commonwealth efforts to provide integrated consumer information
on enrollment, benefits, and choice of One Care plan/providers
Options counseling and information provided by Aging and
Disability Resource Centers and State Health Insurance Assistance
Programs
Initiatives to increase enrollment in the demonstration
Strategies for expanding beneficiary access to demonstration benefits
Emergence of new worker categories/functions (e.g., health coaches,
community care workers)
Strategies implemented to engage beneficiaries in oversight of the
demonstration
Quality management strategy, roles, and responsibilities
Implementation of quality metrics
Adoption of new Commonwealth policies for beneficiary grievances
and appeals based on demonstration experience
Revisions to the demonstration’s initial payment methodology,
including risk-adjustment methodology
Risk-mitigation strategies
Performance incentive approaches
Value-based purchasing strategies

EHR = electronic health records; EMR = electronic medical records; LTSS = long-term services and
supports; QIs = quality improvement initiatives.

3.5

Progress Indicators

In addition to tracking implementation of demonstration design features, we will also
track progress indicators, including growth in enrollment and disenrollment patterns, based on
Massachusetts demonstration data. These progress indicators will be reported quarterly by
Massachusetts through the SDRS, which will be the evaluation team’s tool for collecting and
storing information and for generating standardized tables and graphs for quarterly monitoring
reports for CMS and the Commonwealth. The primary goals of the system are to serve as a
repository for up-to-date information about the Massachusetts demonstration design and
progress, to capture Commonwealth-specific data elements on a quarterly basis, and to monitor
and report on demonstration progress by individual States and the demonstration as a whole.
More detail on the SDRS can be found in the Aggregate Evaluation Plan (Walsh et al., 2013).
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Table 7 presents a summary of progress indicators developed to date. The list of progress
indicators may be refined in consultation with CMS as needed. RTI will provide trainings and an
instruction manual to assist States in using the SDRS.
Table 7
Examples of progress indicators
Indicator

Eligibility
No. of beneficiaries eligible to participate in the demonstration
Enrollment
Total no. of beneficiaries currently enrolled in the demonstration
No. of beneficiaries newly enrolled in the demonstration as of the end of the given month
No. of beneficiaries automatically (passively) enrolled in the demonstration
Disenrollment
No. of beneficiaries who opted out of the demonstration prior to enrollment
No. of beneficiaries who voluntarily disenrolled from the demonstration
No. of beneficiaries whose enrollment in the demonstration ended involuntarily (e.g., died, moved out of
area, lost Medicaid eligibility, were incarcerated)
Demonstration service area
Whether demonstration is currently statewide vs. in specific counties or geographic areas (and provide list
if in specific geographic areas)
Self-direction of personal care services
No. of enrollees in the demonstration who have chosen to self-direct their personal care services
Specific to capitated model demonstrations
No. of three-way contracts with One Care plans

3.6

Data Sources

The evaluation team will use a variety of data sources to assess whether the
Massachusetts demonstration was implemented as planned; identify modifications made to the
design features during implementation; document changes in the time frame or phase-in of key
elements; and determine factors that facilitated implementation or presented challenges. These
data sources include the following:
•

Commonwealth policies and Commonwealth requirements for provider and One
Care plan agreements: The evaluation team will review a wide range of
Commonwealth-developed documents that specify the Massachusetts approach to
implementing its demonstration in order to develop a baseline profile of its current
delivery system. Review of the Massachusetts agreements with CMS articulated
through the demonstration Memorandum of Understanding (MOU), waivers,
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contracts, and State Plan Amendments (if applicable) will further enhance our
understanding of the Massachusetts approach.
•

Demonstration data (collected via the State Data Reporting System): On a
quarterly basis, we will collect data from Massachusetts to inform ongoing analysis
and feedback to the Commonwealth and CMS throughout the demonstration.
Specifically, we will collect data to track policy and operational changes and progress
indicators that are mostly numeric counts of key demonstration elements presented in
Table 7. These demonstration data also may include specific information provided by
CMS or other entities engaged in this demonstration, and incorporated into the State
Data Reporting System.

•

Commonwealth agency staff, stakeholders, selected One Care plans/providers:
There will be at least two sets of site visits; the first one will occur within 6 months of
demonstration implementation. Using two-person teams, supplemented with
telephone interviews, we will obtain perspectives from key informants on progress to
date, internal and external environmental changes, reasons Massachusetts took a
particular course, and current successes and challenges. In addition to the site visits,
and interim calls for clarification about Commonwealth data submitted to the
reporting system, in consultation with CMS we will develop a schedule of quarterly
telephone interviews with various individuals involved in the demonstration.

•

In addition to consumer advocates, as discussed in Section 4.1, Beneficiary
Experience, candidates for key informant interviews on demonstration
implementation include the following:
–

Representatives from Implementation Council

–

Representatives from CMS–State Contract Management Team

–

State officials, such as:
▪

Secretary of Executive Office of Health and Human Services

▪

Medicaid director

▪

Deputy Medicaid director for policy and programs

▪

One Care plan program manager

▪

Contract managers from the Contracted Customer Service and Integrated
Contracting Unit

▪

MassHealth finance managers

▪

Commonwealth representatives from the Interagency Duals Steering
Committee

▪

Commonwealth agencies representing Medicare-Medicaid enrollees aged 21
to 64, including the Department of Mental Health, Department of
Developmental Services, MA Rehabilitation Commission, Executive Office of
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Elder Affairs, MA Commission for the Deaf and Hard of Hearing, and the
MA Commission for the Blind
–

Representatives from selected One Care plans

–

Representatives from providers and provider associations

–

Representatives from the SHINE Program (Serving the Health Information Needs
of Everyone)

–

Representatives from the Medicare-Medicaid Ombuds program

The site visit interview protocols used in the evaluation will contain a core set of
questions that allow us to conduct an aggregate evaluation, questions specific to the financial
alignment model (capitated), as well as a few questions that are specific to the Massachusetts
demonstration. Questions tailored to the key informants in Massachusetts will be developed once
the demonstration is implemented and will be provided to the Commonwealth in advance of the
site visit. The site visit interview protocols with core questions are provided in the Aggregate
Evaluation Plan (Walsh et al., 2013) and will also be tailored for Massachusetts. In advance of
the site visits, the RTI team will contact the Commonwealth to determine the appropriate
individuals to interview. We will work with the Commonwealth to schedule the site visit and the
on-site interviews. We will develop an interview schedule that best suits the needs of the
Commonwealth and key informants we plan to interview.

3.7

Analytic Methods

Evaluation of the Massachusetts demonstration implementation will be presented in an
initial report to CMS and the Commonwealth covering the first 6 months of implementation, in
annual State-specific evaluation reports, and integrated into annual aggregate reports comparing
implementation issues and progress across similar demonstrations and across all demonstrations,
as appropriate. We will collect and report quantitative data quarterly as noted in Table 7,
Examples of Progress Indicators, through the State Data Reporting System. We will integrate
these quantitative data with qualitative data we will collect through site visits and telephone
interviews with Commonwealth agency staff and other key informants, and include these data in
the annual reports and the final evaluation report. These data will provide context for interpreting
the impact and outcomes related to beneficiary experience, quality, utilization, and costs, and
enable us to analyze (1) the changes Massachusetts has made to the preexisting delivery systems
serving Medicare-Medicaid enrollees; (2) challenges Massachusetts has met; and (3) approaches
that can inform adaptation or replication by other States.
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4. Impact and Outcomes
4.1

Beneficiary Experience

4.1.1 Overview and Purpose
The evaluation will assess the impact of the Massachusetts demonstration on beneficiary
experience. Using mixed methods (i.e., qualitative and quantitative approaches), we will monitor
and evaluate the experience of beneficiaries, their families, and caregivers. Our methods will
include the following:
•

the beneficiary voice through focus groups and stakeholder interviews conducted by
RTI;

•

results of Consumer Assessment of Healthcare Providers and Systems (CAHPS) and
any other surveys conducted by Massachusetts, CMS, or other entities;

•

Massachusetts demonstration data and data from other sources submitted via the State
Data Reporting System (SDRS; e.g., data on enrollments, disenrollments, appeals,
grievances, stakeholder engagement activities);

•

claims and encounter data obtained from CMS will be used to analyze utilization as
well as access to services and outcomes for key quality measures; and

•

interviews with Massachusetts demonstration staff during site visit or telephone
interviews with RTI.

Table 8 (described in more detail below) shows the range of topics and data sources we
will use to monitor and evaluate beneficiary experience. We are interested in the perspective of
the beneficiaries themselves, determining specifically the impact of the demonstration on their
access to needed services, the integration and coordination of services across settings and
delivery systems, provider choice, enrollee rights and protections, and the provision of personcentered care. In the process, we will identify what has changed for beneficiaries since their
enrollment in the demonstration and its perceived impact on their health and well-being.
This section of the evaluation plan focuses specifically on the methods we will use to
monitor and evaluate beneficiary experience, such as focus groups with beneficiaries and
interviews with consumer and advocacy groups. We also discuss information about data we will
obtain from Massachusetts through interviews and the SDRS, and results of beneficiary surveys
that may be administered and analyzed independent of this evaluation by the Commonwealth,
CMS, or by other entities.
Through beneficiary focus groups and key stakeholder interviews (i.e., consumer and
advocacy group members), we also will explore whether we can identify specific demonstration
features in Massachusetts that may influence replication in other States. We will also collect
information from Commonwealth demonstration staff and CMS or other entities that reflects the
beneficiaries’ experiences (e.g., grievances and appeals, disenrollment patterns) using RTI’s
Massachusetts Evaluation Design Plan — December 23, 2013
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State Data Reporting System. Section 3, Demonstration Implementation Evaluation, describes
topics we will monitor and document through interviews with Massachusetts demonstration staff
and document reviews, including consumer protections and other demonstration design features
intended to enhance the beneficiary experience. Refer to Section 4.2 for a discussion of the use
of claims and encounter data to establish baseline information about the beneficiaries eligible for
the demonstration, and how we will use these data to inform our understanding of the impact of
the Commonwealth’s demonstration on its access to care and health outcomes.
Specifically, we will address the following research questions in this section:
•

What impact does the Massachusetts demonstration have on the beneficiary
experience overall and for beneficiary subgroups?

•

What factors influence the beneficiary enrollment decision?

•

Do beneficiaries perceive improvements in their ability to find needed health
services?

•

Do beneficiaries perceive improvements in their choice of care options, including
self-direction?

•

Do beneficiaries perceive improvements in how care is delivered?

•

Do beneficiaries perceive improvements in their personal health outcomes?

•

Do beneficiaries perceive improvements in their quality of life?

4.1.2 Approach
This mixed-method evaluation will combine qualitative information from focus groups
and key stakeholder interviews with quantitative data related to beneficiary experience derived
from the RTI State Data Reporting System and findings from surveys that may be conducted
independently by Massachusetts, CMS, or other entities (e.g., CAHPS). Qualitative data will be
obtained directly from a beneficiary or beneficiary representative through focus groups and
interviews. To avoid potential bias or conflict of interest, we will apply a narrow definition of
“representative” to include only family members, advocates, or members of organizations or
committees whose purpose is to represent the interest of beneficiaries and who are not service
providers or do not serve in an oversight capacity for the initiative. Although no baseline
qualitative data are available, beneficiaries will be asked about their experience before the
demonstration and how it may have changed during the course of the demonstration.
Our framework for evaluating beneficiary experience is influenced by work conducted by
the Center for Health Care Strategies (CHCS), which identified essential elements of integration
affecting beneficiary experience, including the care process and quality of life (Lind and Gore,
2010). Its work is intended to guide the design of integrated care systems for Medicare-Medicaid
enrollees and to do so in ways that strengthen the beneficiary experience in the areas defined in
Table 8.
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Beneficiary
focus groups

Recommended
survey
question1

Massachusetts
demonstration
data2

X

X

X

X

X

Beneficiaries have choice of medical,
behavioral, and LTSS providers within the
network.

X

X

X

X

X

Beneficiaries have choice to self-direct their
care.

X

X

—

X

X

Beneficiaries are empowered and supported to
make informed decisions.

X

X

—

—

—

X

X

X

X

—

X

X

—

X

—

X

X

X

X

—

X

X

—

—

X

Direct measure
Integrated delivery system
Choice
Beneficiaries have choice of medical,
behavioral, and LTSS services.

Provider network
Beneficiaries report that providers are available
to meet routine and specialized needs.
Beneficiaries report that LTSS and behavioral
health are integrated into primary and specialty
care delivery.
Beneficiary engagement
Beneficiaries consistently and meaningfully
have the option to participate in decisions
relevant to their care.
There are ongoing opportunities for beneficiaries
to be engaged in decisions about the design and
implementation of the demonstration.
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Table 8
Methods for assessing beneficiary experience by beneficiary impact

Massachusetts
demonstration
data2

Interviews with
Massachusetts
agency staff on
demonstration
implementation

Beneficiary
focus groups

Streamlined processes
Beneficiaries can easily navigate the delivery
system.

X

X

—

X

—

Reduced duplication of services
Beneficiary burden is reduced through
elimination of duplicative tests and procedures.

—

—

—

X

—

X

X

—

X

X

Beneficiaries report ease of disenrollment.

X

X

—

X

—

Rate of beneficiaries who opt out of enrolling
into demonstration.

—

—

—

X

—

Rate of disenrollment from the demonstration,
by reason.

—

—

—

X

—

X

X

—

X

—

Beneficiaries report improved quality of life due
to access to the full range of services.

X

X

X

—

—

Beneficiaries report that waiting times for
routine and urgent primary and specialty care are
reasonable.

X

X

—

X

—

Direct measure

Enrollment and access to care
Enrollment
Beneficiaries have choices and assistance in
understanding their enrollment options.

Access to care
Beneficiaries can access the full range of
scheduled and urgent medical care, behavioral
health services, and LTSS.
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Massachusetts
demonstration
data2

Interviews with
Massachusetts
agency staff on
demonstration
implementation

Beneficiary
focus groups

Health Outcomes
Beneficiary health rating.

—

—

X

—

—

Quality of Life
Days free from pain.

—

—

X

—

—

Beneficiaries get the social and emotional
supports they need.

—

X

X

—

—

Beneficiaries report that they are satisfied with
their life.

—

X

X

—

—

X

X

—

X

X

X

X

—

X

—

X

X

—

—

X

Beneficiaries report that providers are
knowledgeable about them and their care
history.

X

X

—

X

—

Beneficiaries have adequate discharge and
referral instructions.

X

X

—

X

X

Beneficiaries report that providers follow up
after visits or discharge.

X

X

—

X

—

Beneficiaries understand their options to specify
that personal health data not be shared.

X

X

—

X

—

Direct measure

Cultural appropriateness
Beneficiaries have access to multilingual and
culturally sensitive providers.
Beneficiaries report that written and oral
communications are easy to understand.
Delivery systems supports
Data sharing and communication
Information is available and used by
beneficiaries to inform decisions.
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Beneficiary
focus groups

Recommended
survey
question1

Massachusetts
demonstration
data2

X

X

—

X

X

Medical providers actively participate in
individual care planning.

—

X

X

—

—

Beneficiaries report active participation in the
assessment process.

X

X

—

X

—

X

X

—

X

—

Beneficiaries report that care managers have the
skills and qualifications to meet their needs

—

X

X

—

—

Beneficiaries report that providers listen
attentively and are responsive to their concerns.

X

X

X

X

—

X

X

X

X

—

Beneficiaries have supports and resources to
assist them in accessing care and selfmanagement.

X

X

—

X

—

Beneficiaries report ease of transitions across
providers and settings.

X

X

X

X

—

Direct measure
Care coordination
Assessment of need
Assessment process integrates/addresses health,
behavioral health, and LTSS.

Person-centered care
Care is planned and delivered in a manner
reflecting a beneficiary’s unique strengths,
challenges, goals, and preferences.

Coordination of care
The system facilitates timely and appropriate
referrals and transitions within and across
services and settings.
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Table 8 (continued)
Methods for assessing beneficiary experience by beneficiary impact

Direct measure
Family and caregiver involvement
Beneficiaries have the option to include family
and/or caregivers in care planning.
The family or caregiver’s skills, abilities, and
comfort with involvement are taken into account
in care planning and delivery.
Benefits and services
Awareness of covered benefits
Beneficiaries are aware of covered benefits.
Availability of enhanced benefits
The demonstration covers important services to
improve care outcomes that are not otherwise
available through Medicaid or Medicare program.
Flexible benefits are available to meet the needs of
beneficiaries.
Awareness of enhanced benefits
Beneficiaries are aware of enhanced benefits and
use them.

Beneficiaries are treated fairly, are informed of
their choices, and have a strong and respected
voice in decisions about their care and support
services.

Beneficiary
focus groups

Recommended
survey
question1

Massachusetts
demonstration
data2

X

X

—

X

—

X

X

—

X

—

X

X

—

X

—

—

—

—

X

X

—

—

—

X

X

X

X

—

X

—

X

X

—

X

—

X

X

—

X

—
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Beneficiaries understand their rights.
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Key stakeholder
interviews

Beneficiary
focus groups

Recommended
survey
question1

Massachusetts
demonstration
data2

Interviews with
Massachusetts
agency staff on
demonstration
implementation

X

X

—

X

—

—

—

—

X

—

X

X

—

X

—

X

—

—

—

X

Rate of auto-assignment (if available).

—

—

—

X

—

Rate of change of PCP requests (if available).

—

—

—

X

—

Direct measure
Complaints, grievances, and appeals
Beneficiaries have easy access to fair, timely, and
responsive processes when problems occur.
Number and type of beneficiary complaints,
grievance, and appeals.
Advocacy/member services
Beneficiaries get assistance in exercising their
rights and protections.
Finance and payment
Provider incentives
Beneficiary experience is taken into account
when awarding provider and plan incentives.
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— = no data for cell; HCBS = home and community-based services; LTSS = long-term services and supports; PCP = primary care provider.
1

The evaluation team will recommend questions to add to surveys conducted by Massachusetts or CMS.
Drawn from State Data Reporting System, RTI analysis of administrative data, Consumer Assessment of Healthcare Providers and Systems (CAHPS) or Health
Outcomes Survey (HOS) results, or from other beneficiary surveys that may be conducted by the Commonwealth or other entities.

2
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Table 8 aligns key elements identified in the CHCS framework with the demonstration
design features described in Section 3, Demonstration Implementation Evaluation. We
modified some elements of the CHCS framework to reflect that not all Medicare-Medicaid
enrollees require intensive services as suggested by the original CHCS language used when
describing comprehensive assessments and multidisciplinary care teams. For each key element,
we identify the impact on beneficiary experience and detail the data sources that RTI will use to
obtain the information.
As shown in Table 8, we will solicit direct feedback from beneficiaries served through
the demonstration to determine how closely their experience compares to the desired outcomes
(improvements in personal health outcomes, quality of life, how beneficiaries seek care, choice
of care options, and how care is delivered). We will include topics specific to the demonstration
and supplement our understanding of direct beneficiary experience with key stakeholder
interviews (e.g., consumer and advocacy groups), a review of enrollment and disenrollment,
grievances and appeals, claims and encounter data analysis, and interviews with Massachusetts
staff on demonstration implementation.
Table 9 highlights some of the quantitative measures of beneficiary experience we will
monitor and evaluate using demonstration statistics and claims or encounter data analysis. See
Section 4.2 for a discussion of the quality, utilization, and access to care measures we plan to
examine as part of the overall evaluation of impact of the Massachusetts demonstration on
beneficiary outcomes, including for subpopulations. The draft focus group protocol and the draft
stakeholder interview protocol are both discussed in this section and are available in the
Aggregate Evaluation Plan (Walsh et al., 2013).
We will analyze our findings by subpopulation. When we can recruit sufficient numbers
of individuals from the subpopulations of interest to participate in the focus groups, we will also
analyze our focus group findings about beneficiary experience to determine whether differences
exist by subpopulation.
Table 9
Demonstration statistics on quality, utilization, and access to care measures
of beneficiary experience
Rate of auto-assignment to One Care plans (if available)
Rate of disenrollment from the demonstration by reason1
Rate of beneficiaries who opt out of enrolling into demonstration
Number and type of beneficiary complaints, grievance, and appeals
Use of preventive services1
Nursing facility admissions and readmissions1
Emergency room use1
Hospital admission and readmission rates1
Follow-up care after hospital discharge1
1

See Section 4.2, for discussion of specific measures.
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4.1.3 Data Sources
We will rely on five major data sources to assess beneficiary experience as shown in
Table 8. In this section, we describe our plan for using focus group and stakeholder interviews;
results of beneficiary surveys planned by the Commonwealth, CMS, or other entities (e.g.,
CAHPS); the Commonwealth demonstration data entered into the State Data Reporting System;
and interviews with Commonwealth demonstration staff.
4.1.3.1 Focus Groups
We will conduct four focus groups in Massachusetts to gain insight into how the initiative
affects beneficiaries. To ensure that we capture the direct experience and observations of those
served by the Massachusetts demonstration, focus groups will be limited to demonstration
enrollees, their family members, and informal caregivers. Table 10 shows our current plan for
the composition and number of focus groups.
We are aware that Massachusetts has conducted its own focus groups during the
planning/design phase of its initiative and may continue to do so during the demonstration
period. We will use findings from the Commonwealth’s activities to inform the content of the
guides we use in conducting the focus groups. Preliminary topics of the focus groups include
beneficiaries’ understanding of the demonstration, rights, options, and choices (e.g., plan,
primary care provider); reasons beneficiaries choose to enroll and disenroll; their benefits;
concerns or problems encountered; experience with care coordination; and access to primary and
specialty care. Timing for conducting the focus groups will be influenced by our assessment of
whether there is more to be learned about the experience of beneficiaries shortly after initial
enrollment into the Massachusetts demonstration versus their perceptions of its effectiveness
later in the Massachusetts demonstration. If the latter, we will conduct focus groups at least 1
year after implementation so that beneficiaries have had a substantial amount of experience with
the demonstration. We will make the decision regarding timing of the focus groups in
conjunction with CMS.
Table 10
Purpose and scope of Commonwealth focus groups
Primary purpose

To understand beneficiary experience with the demonstration and, where possible, to identify
factors and design features contributing to their experience.

Composition

Each focus group includes 8–10 individuals who may be beneficiaries or family members or
caregivers representing beneficiaries. These may include but are not limited to beneficiaries
aged 21 to 64 with
● developmental disabilities
● severe and persistent mental illness
● substance use disorders
● long-term services and supports (LTSS) use
● multiple chronic conditions
● serious physical disabilities

Number

Four focus groups
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We will recruit focus group participants from eligibility and enrollment files independent
of input from the Commonwealth. In doing so, we will identify beneficiaries reflecting a range of
eligibility, clinical, and demographic characteristics enrolled in the Massachusetts demonstration.
Our subcontractor, the Henne Group, will use a structured approach for screening potential
participants and obtaining their agreement to participate. If there appear to be high initial rates of
opting out or disenrollment from the demonstration in Massachusetts, we will consider
convening focus groups with beneficiaries who have chosen to opt out or disenroll, to understand
their decisions. We will work closely with Massachusetts demonstration staff to make the
process of recruiting focus group members as smooth as possible for beneficiaries, such as
selecting an accessible site and ensuring transportation and any needed special accommodations
and supports to allow for full participation. Focus group recruitment and all focus group
arrangements will be conducted with an awareness of the subpopulations of concern in
Massachusetts. We will investigate the prevalence of non-English–speaking beneficiaries in the
eligible population, and determine whether to hold any of the focus groups in languages other
than English. A preliminary focus group protocol is presented in the Aggregate Evaluation Plan
(Walsh et al., 2013). The protocol may be modified based on final decisions about focus group
composition, content, and our understanding of issues raised during implementation of the
Massachusetts demonstration.
4.1.3.2 Key Stakeholder Interviews
Our evaluation team will conduct key stakeholder interviews (consumer and advocacy
groups) in Massachusetts, either in person as part of a scheduled site visit or by telephone, with
major beneficiary groups whose stakeholders are served by the Massachusetts demonstration.
The purpose of these interviews will be to assess the level of beneficiary engagement and
experience with the demonstration and its perceived impact on beneficiary outcomes. Although
we will interview service providers as part of our implementation analyses, service provider
perspectives will not be the source of information for assessing beneficiary experience.
Table 11 identifies potential groups in Massachusetts whose representatives we may wish
to interview and the overall purpose of the interview. We will finalize the list of key stakeholders
following discussions with demonstration staff in Massachusetts, a review of events and issues
raised during the development of the demonstration, and the composition of enrollment by
subpopulations.
A draft outline of the key stakeholder interview at baseline is presented in the Aggregate
Evaluation Plan (Walsh et al., 2013). We will revise this draft as we obtain more information
about the Massachusetts demonstration and the issues that arise during its planning/design phase
and early implementation.
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Table 11
Preliminary subpopulations and scope of key stakeholder interviews
Primary
purpose

Baseline: Assess understanding of and satisfaction with demonstration design; expectations for the
demonstration; perceived concerns and opportunities.
Throughout demonstration: Spot improvements and issues as they emerge and assess factors
facilitating and impeding positive beneficiary experience.
Final year: Assess extent to which expectations were met; major successes and challenges;
lessons learned from beneficiary’s perspective.

Subpopulations Interviews will be held with consumer and advocacy groups whose members are served by the
Massachusetts demonstration. These may include the following:
● Advocacy and consumer organizations representing the demonstration’s eligible
●
●
●
●
Number and
frequency

populations
Advocacy and consumer organizations participating in the Massachusetts Medicaid
Advisory Committee and its subcommittees
Beneficiaries and/or consumer organizations serving on the Implementation
Council for the Massachusetts demonstration
Beneficiaries serving on One Care plan Consumer Advisory Committees
Beneficiary advocates

Baseline: Up to eight telephone interviews within 6 months after implementation.
Throughout demonstration: Up to eight telephone or in-person interviews in Massachusetts each
year to be conducted with the same individuals each time, unless other stakeholders or topics of
interest are identified.
Final year: Up to eight telephone or in-person interviews.

4.1.3.3 Beneficiary Surveys
The RTI evaluation team will not directly administer any beneficiary surveys as part of
the evaluation, and we are not requiring that States administer beneficiary surveys for purposes
of the evaluation. We will include relevant findings from beneficiary surveys already being
conducted for this demonstration by Massachusetts, CMS, or other entities. We understand that
One Care plans will be required to conduct a beneficiary experience survey and a Quality of Life
survey, although final decisions on the content of the beneficiary survey have not been made. We
will recommend standard questions for inclusion in surveys across all Financial Alignment
Demonstrations, such as quality of life measures. Should Massachusetts be amenable to
including these questions in the surveys to be conducted by the One Care plans, we will
participate in discussions with the Commonwealth and CMS (and other CMS contractors, as
appropriate) regarding content and sampling issues. Topics on which we will recommend
common questions across State demonstrations are shown in Table 8.
As part of CMS requirements for capitated managed care plans, One Care plans will be
required to conduct the Health Outcomes Survey (HOS) and CAHPS. The Medicare CAHPS and
HOS surveys will be sampled at the One Care plan level, allowing cross-plan and aggregate
comparisons, where appropriate.
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4.1.3.4 Demonstration Data
We will use data about the demonstration that we collect from Massachusetts during site
visits, from reports and other materials developed by the Commonwealth, through the State Data
Reporting System, and data obtained from CMS or other entities to assess the beneficiary
experience. Data of particular interest include the following:
•

Complaint, appeal, and grievance data from CMS or other entities, as available.

•

Disenrollment and opt-out rates.

•

Information about waiting lists or lags in accessing services, which will provide
useful indications of where the system lacks capacity, as a topic for discussion during
site visits or focus groups.

•

Rate of change in primary care provider (PCP) assignment (if available).

The above quantitative indirect measures will be collected for all Medicare-Medicaid
enrollees served under the demonstration and will be analyzed by subpopulations.
In addition, Massachusetts plans to monitor quality using a selection of national
measures, CMS/Commonwealth-defined process measures, and Commonwealth-specified
measures (Memorandum of Understanding [MOU], 2012, pp. 93–105). To the extent relevant,
we will use findings from these State-specific metrics to augment our assessment of beneficiary
experience and outcomes in Massachusetts.
4.1.3.5 Interviews with Massachusetts Demonstration Staff
In addition to key stakeholder interviews conducted with consumer and advocacy groups,
we will address issues of beneficiary engagement and feedback during our interviews with
Massachusetts demonstration staff. These interviews, described in Section 3, will provide
another perspective on how Massachusetts communicates and works with beneficiaries during
the design and implementation of its demonstration.

4.1.4 Analytic Methods
Our analysis will assess beneficiary experience and determine, where possible, how it is
affected by financial model and demonstration design features. We also want to examine whether
and how beneficiary experience varies by subpopulations. The Henne Group will audio-record
all focus groups, subject to approval of the group members, and the audio-recordings will be
transcribed. Key stakeholder interview and focus group transcripts will be imported and analyzed
using QSR NVivo 9, qualitative data analysis software, to identify emergent themes and patterns
regarding beneficiary experiences during the demonstration and issues related to the evaluation
research questions. A structured approach to qualitative analysis in NVivo 9 will allow us to
identify themes in Massachusetts and compare and contrast those themes by subpopulation
within and across States. Because it is implementing a demonstration using the capitated
financial alignment model, we are particularly interested in comparing the Massachusetts
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findings with those of other States’ capitated model demonstrations and in determining whether
particular design features in this State’s demonstration are likely to affect beneficiary experience.
Most demonstration data will be collected and tracked through the State Data Reporting
System and analyzed using descriptive statistics reported quarterly through that system. We will
also request summary statistics and reports from Massachusetts on its beneficiary experience and
Quality of Life surveys and others that may be required. Information from site visits and sitereported data beyond those described specifically in this section also are expected to inform
analysis of beneficiary experience research questions. The findings will be grouped into the
beneficiary experience domains defined in Section 4.1.2.
As noted, the Commonwealth has conducted focus groups prior to the demonstration, and
further indications of predemonstration beneficiary experience may be available from other
sources. The evaluation will not, however, have baseline data or comparison group results in this
area. Results of beneficiary surveys, focus groups, and other approaches employed during the
demonstration period will be presented in the annual and final evaluation reports along with
available context to inform interpretation.

4.2

Analyses of Quality, Utilization, Access to Care, and Cost

4.2.1 Purpose
This section of the report outlines the research design, data sources, analytic methods,
and key outcome variables (quality, utilization, and cost measures) on which we will focus in
evaluating the Massachusetts demonstration. These analyses will be conducted using secondary
data, including Medicare and Medicaid claims and managed care encounter data. This section
addresses the following research questions:
•

What impact does the Massachusetts demonstration have on utilization patterns in
acute, long-term, and behavioral health services, overall and for beneficiary
subgroups?

•

What impact does the Massachusetts demonstration have on health care quality
overall and for beneficiary subgroups?

•

Does the Massachusetts demonstration change access to care for medical, behavioral
health, long-term services and supports (LTSS) overall and for beneficiary
subgroups? If so, how?

•

What impact does the Massachusetts demonstration have on cost and is there
evidence of cost savings in the Commonwealth? How long did it take to observe cost
savings in the Commonwealth? How were these savings achieved in the
Commonwealth?

In this section, we discuss our approach to identifying the eligible population for
Massachusetts and for identifying comparison group beneficiaries. This section also describes
the data sources, key analyses to be performed over the course of the demonstration, and the
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quality measures that will inform the evaluation. RTI will use both descriptive and multivariate
analyses to evaluate the Massachusetts demonstration. Results of descriptive analyses focusing
on differences across years and important subgroups on key outcome variables will be included
in the Massachusetts quarterly reports to CMS and the Commonwealth and annual reports.
Multivariate analyses of each year of demonstration data will be included in the final evaluation.
Savings will be calculated at least twice during the demonstration period: once during the
demonstration and once after the end of the demonstration.

4.2.2 Approach
An appropriate research design for the evaluation must consider whether selection is a
risk for bias. Potential sources of selection bias exist in the Massachusetts demonstration
whereby the beneficiaries choosing not to enroll in the demonstration may differ from
demonstration participants. First, beneficiaries may choose to opt out or disenroll from the
demonstration. Reasons for opting out or disenrolling will vary but may be related to
demonstration benefits or previous experience in a One Care plan. Second, beneficiaries already
enrolled in a Medicare Advantage plan or Program of All Inclusive Care for the Elderly (PACE)
will not be eligible for passive enrollment into the demonstration, but can choose to disenroll
from their current plans. To limit selection bias in the evaluation of this demonstration, we will
use an intent-to-treat design. This design will address potential selection bias issues by including
the entire population of beneficiaries eligible for the Massachusetts demonstration, regardless of
whether they enroll in a One Care plan or actively participate in the care model.
Under the intent-to-treat framework, outcome analyses will include all beneficiaries
eligible for the demonstration in the demonstration States, including those who opt out,
participate but then disenroll, are eligible but are not contacted by the State or participating
providers, and those who enroll but do not engage with the care model, and a group of similar
individuals in the comparison group. This approach diminishes the potential for selection bias
and highlights the effect of the demonstrations on all beneficiaries in the demonstration-eligible
population. In addition, RTI will compare the characteristics of those who enroll with those who
are eligible but do not enroll in the care model and conduct analyses to further explore
demonstration effects on demonstration enrollees, acknowledging that interpreting such results
will be difficult given likely selection bias.
4.2.2.1 Identifying Demonstration Group Members
The demonstration group for Massachusetts will include full-benefit Medicare-Medicaid
enrollees aged 21 to 64 years old, including individuals with severe and persistent mental illness,
drug dependence, substance use disorders, and chronic physical conditions. To analyze quality,
utilization, and costs in the predemonstration period, and throughout the demonstration period,
Massachusetts will submit a demonstration evaluation (finder) file that includes data elements
needed for RTI to correctly identify Medicare-Medicaid enrollees for linking to Medicare and
Medicaid data, and information about whether the enrollees were eligible for or enrolled in a
Financial Alignment Demonstration (Table 12). The file will list all of the Medicare-Medicaid
eligible population for the demonstration, with additional variables in the file indicating monthly
participation in the demonstration. Eligible individuals who were not enrolled in the
demonstration in a given month will still be part of the evaluation under the intent-to-treat
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research design. In addition to indicating who was eligible and enrolled, this file will contain
personal identifying information for linking to Medicare and Medicaid data. RTI will notify the
State about the file's design and the method and timing of transmission after the start of the
demonstration.
Table 12
State demonstration evaluation (finder) file data fields
Data field

Length Format

Valid value

Description

Medicare Beneficiary
Claim Account
Number (Health
Insurance Claim
Number [HICN])

11

CHAR

Alphanumeric

The HICN. Any Railroad Retirement Board
(RRB) numbers should be converted to the
HICN number prior to submission to the
MDM.

MSIS number

20

CHAR

Alphanumeric

MSIS identification number.

Social security number
(SSN)

9

CHAR

Numeric

Individual's SSN.

Sex

1

CHAR

Alphanumeric

Sex of beneficiary (1=male or 2=female).

Person first name

30

CHAR

Alphanumeric

The first name or given name of the
beneficiary.

Person last name

40

CHAR

Alphanumeric

The last name or surname of the beneficiary.

Person birth date

8

CHAR

CCYYMMDD The date of birth (DOB) of the beneficiary.

Person ZIP code

9

CHAR

Numeric

9-digit ZIP code.

Eligibility
identification flag

1

CHAR

Numeric

Coded 0 if identified as not eligible for the
demonstration, 1 if identified as eligible from
administrative data, 2 if identified as eligible
from nonadministrative data.

Monthly enrollment
indicator

1

CHAR

Numeric

Each monthly enrollment flag variable would
be coded 1 if enrolled, and zero if not.
Quarterly demonstration evaluation (finder)
files would have 3 such data fields; annual
demonstration evaluation (finder) files would
have 12 such data fields.

MDM = Master Data Management; MSIS = Medicaid Statistical Information System.

4.2.2.2 Identifying a Comparison Group
The methodology described in this section reflects the plan for identifying comparison
groups based on discussions between RTI and CMS and detailed in the Aggregate Evaluation
Plan (Walsh et al., 2013). Identifying the comparison group members will entail two steps:
(1) selecting the geographic area from which the comparison group will be drawn and
(2) identifying the individuals who will be included in the comparison group.
Because most Massachusetts counties and demonstration-eligible beneficiaries will be
included in the demonstration area, we will most likely consider a comparison group from outof-State Metropolitan Statistical Areas (MSAs). In general, we expect to draw out-of-State
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comparison groups from multiple comparison States and areas. However, if for any reason the
Massachusetts demonstration is not implemented statewide, we will determine whether there are
areas within Massachusetts that could also be part of the comparison group. The approach for
identifying in-State comparison areas would be the same as the process for identifying an out-ofState comparison group, described below.
We will use statistical distance analysis to identify potential comparison areas that are
most similar to Massachusetts in regard to costs, care delivery arrangements, and policy affecting
Medicare-Medicaid enrollees. The specific measures for the statistical distance analysis we will
use are Medicare spending per Medicare-Medicaid enrollee, Medicaid spending per MedicareMedicaid enrollee, nursing facility users per 65-and-over Medicaid enrollee, home and
community-based (HCBS) users per 65-and-over Medicaid enrollee, Personal Care users per 65and-over Medicaid enrollee, Medicare Advantage penetration, and Medicaid managed care
penetration for full-benefit Medicare-Medicaid enrollees. The three LTSS variables capture how
areas differ in the settings in which they provide these services. Variation in LTSS policy is most
easily visible in the population using the most LTSS (i.e., those aged 65 and over). The relative
importance of institutional care observed in that population is expected to affect such use in the
population under age 65 as well.
Once comparison areas are selected, all Medicare-Medicaid enrollees in those States who
meet the demonstration’s eligibility criteria will be selected for comparison group membership
based on the intent-to-treat study design. The comparison areas will be determined within the
first year of demonstration implementation, in order to use the timeliest data available. The
comparison group members will be determined retrospectively at the end of each demonstration
year, allowing us to include information on individuals newly eligible or ineligible for the
demonstration during that year. The comparison group will be refreshed annually to incorporate
new entrants into the eligible population as new individuals become eligible for the
demonstration over time. To ensure that the comparison group is similar to the demonstration
group, we will compute propensity scores and weight comparison group beneficiaries using the
framework described in Section 4.2.2.4 of this report.
4.2.2.3 Issues/Challenges in Identifying Comparison Groups
The RTI team will make every effort to account for the following four issues/challenges
when identifying and creating comparison groups.
1. Similarities between demonstration and comparison groups: Comparison group
members are as much like demonstration group members as possible and sufficient
data are needed to identify and control for differences.
2. Sample size: Given that the team plans to use all comparable beneficiaries in an outof-State comparison group that would be eligible for the demonstration, we expect to
have sufficient sample size for the statewide analyses and for analyses of smaller
subpopulations.
3. Accounting for enrollment in other demonstrations: Some Medicare-Medicaid
enrollees may not be suitable for comparison group selection because of participation
in other demonstrations or enrollment in Accountable Care Organizations. We will
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work with CMS to specify these parameters and apply them to both Massachusetts
and the comparison group.
4. Medicaid data: Significant time delays currently exist in obtaining Medicaid data. If
unaddressed, this could result in delays in formulating appropriate comparison
groups. Timeliness of Medicaid Statistical Information System (MSIS) data
submissions will need to be considered if out-of-State comparison areas are required
for the evaluation.
4.2.2.4 Propensity Score Framework for Identifying Comparison Group Members
Because comparison group members may differ from the demonstration group on
individual characteristics, we will compute propensity scores for the demonstration and
comparison group members. The propensity score represents how well a combination of
characteristics, or covariates, predicts that a beneficiary is in the demonstration group. To
compute these scores for beneficiaries in the demonstration and comparison groups, we will first
identify beneficiary- and market-level characteristics to serve as covariates in the propensityscore model. Beneficiary-level characteristics may include demographics, socioeconomic, health,
and disability status, and county-level characteristics may include health care market and local
economic characteristics. Once the scores are computed, we will remove from the comparison
group any beneficiaries with a propensity score lower than the lowest score found in the
demonstration group to ensure that the comparison group is similar to the demonstration group.
The propensity scores for the comparison group will then be weighted so that the
distribution of characteristics of the comparison group is similar to that of the demonstration
group. By weighting comparison group members’ propensity scores, the demonstration and
comparison group samples will be more balanced. More detail on this process is provided in the
Aggregate Evaluation Plan (Walsh et al., 2013).

4.2.3 Data Sources
Table 13 provides an overview of the data sources to be used in the Massachusetts
evaluation of quality, utilization, and cost. Data sources include Medicare and Medicaid fee-forservice data, Medicare Advantage encounter data, and Medicare-Medicaid Plan encounter data.
These data will be used to examine quality, utilization, and cost in the predemonstration period
and during the demonstration. Data will be needed for all beneficiaries enrolled in the
demonstration as well as other beneficiaries in the eligible population who do not enroll. Note
that data requirements for an individual beneficiary will depend on whether they were in
Medicare fee-for-service or Medicare Advantage in the pre- and postdemonstration periods.
The terms of the Massachusetts MOU require the Commonwealth to provide timely
Medicaid data through MSIS submissions for the predemonstration and demonstration periods.
Any delays in obtaining data may also delay portions of the evaluation.
The activities to identify demonstration and comparison groups and to collect and utilize
claims and encounter data may be revised if modifications are made to the demonstrations or if
data sources are not available as anticipated. If modifications to this evaluation plan are required,
they will be documented in the annual and final evaluation reports as appropriate.
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Aspect

Medicare fee-for-service data

Encounter data1

Medicaid fee-for-service data

CMS

CMS

CMS

Description and uses
of data

Will be pulled from
● Part A (hospitalizations) and
● Part B (medical services).
Will be used to evaluate quality of care,
utilization, and cost during the
demonstration. These data will also be
used for beneficiaries who opt out of
the demonstration, have disenrolled, or
do not enroll for other reasons; for
predemonstration analyses of
demonstration-eligible beneficiaries for
the 2 years prior to the demonstration;
and for comparison groups that may be
in-state or out-of state.

Medicaid claims and enrollment data will
include data on patient characteristics,
beneficiary utilization, and cost of services.
Eligibility files will be used to examine
changes in number and composition of
Medicare-Medicaid enrollees. Will also
need these data for beneficiaries who opt
out of the demonstration, have disenrolled,
or do not enroll for other reasons; for
predemonstration analyses of
demonstration-eligible beneficiaries for the
2 years prior to the demonstration; and for
comparison groups.

Pre- and postperiod beneficiary encounter data
(including Medicare Advantage, and MedicareMedicaid Plan, and Part D data) will contain
information on
● beneficiary characteristics and diagnoses,
● provider identification/type of visit, and
● beneficiary IDs (to link to Medicare and
Medicaid data files).
Will be used to evaluate quality (readmissions),
utilization, and cost; health; access to care; and
beneficiary satisfaction. Part D data will be used
to evaluate cost only. These data will also be used
for beneficiaries who opt out of the
demonstration, have disenrolled, or do not enroll
for other reasons; for predemonstration analyses
of demonstration-eligible beneficiaries for the 2
years prior to the demonstration; and for
comparison groups that may be in-state or out-of
state.

Sources of data

Will be pulled from the following:
● NCH Standard Analytic File
● NCH TAP Files
● Medicare enrollment data

Will be pulled from the following:
● MSIS (file on inpatient care,
institutional, and the “other” file)
● Medicaid eligibility files

Data will be collected from the following:
● CMS
● Medicare enrollment data
(continued)
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Table 13
Data sources to be used in Massachusetts Financial Alignment Demonstration evaluation analyses of quality, utilization,
and cost

Aspect

Encounter data1

Medicare fee-for-service data

Medicaid fee-for-service data

Time frame of data

Baseline file = 2 years prior to the
demonstration period (NCH Standard
Analytic File).
Evaluation file = all demonstration
years (NCH TAP Files).

Baseline file = 2 years prior to the
demonstration period.
Evaluation file = all demonstration years.

Baseline file = Medicare Advantage plans submit
encounter data to CMS as of January 1, 2012.
RTI will determine to what extent these data can
be used in the baseline file.
Evaluation file = Medicare Advantage and One
Care plans are required to submit encounter data
to CMS for all demonstration years.

Potential concerns

—

Expect significant time delay for all Medicaid
data.

CMS will provide the project team with data
under new Medicare Advantage requirements.
Any lags in data availability are unknown at this
time.

— = no data; MSIS = Medicaid Statistical Information System; NCH = National Claims History; TAP = monthly Medicare claims files.
1

Encounter data from Medicare Advantage (MA) or PACE plans in the pre-period are needed to evaluate demonstration effects for beneficiaries who previously
were enrolled in Medicare Advantage or PACE plans but who enroll in the demonstration. There may also be movement between Medicare Advantage or PACE
plans and the demonstration throughout implementation, which we will need to take into account using Medicare Advantage or PACE encounter data during the
implementation period.
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Table 13 (continued)
Data sources to be used in Massachusetts Financial Alignment Demonstration evaluation analyses of quality, utilization,
and cost

Notes on Data Access: CMS data contain individually identifiable data that are protected under the Health Insurance Portability and Accountability Act (HIPAA)
of 1996. CMS, however, makes data available for certain research purposes provided that specified criteria are met. RTI has obtained the necessary Data Use
Agreement (DUA) with CMS to use CMS data. A listing of required documentation for requesting CMS identifiable data files such as Medicare and MSIS is
provided at http://www.resdac.umn.edu/medicare/requesting_data.asp.
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Analyses

The analyses of quality, utilization, and cost in the Massachusetts evaluation will consist
of the following:
1. a monitoring analysis to track quarterly changes in selected quality, utilization, and
cost measures over the course of the Massachusetts demonstration (as data are
available);
2. a descriptive analysis of quality, utilization, and cost measures for annual reports
with means and comparisons for subgroups of interest, including comparison group
results; and
3. multivariate difference-in-differences analyses of quality, utilization, and cost
measures using an in-State or out-of-State comparison group, depending on whether
the demonstration is implemented statewide.
At least one multivariate regression-based savings analysis will be calculated during the
demonstration period, most likely using 2 years of demonstration data. A second savings analysis
will be included in the final evaluation.
The approach to each of these analyses is outlined below in Table 14.
Table 14
Quantitative analyses to be performed for Massachusetts demonstration
Aspect

Monitoring analysis

Descriptive analysis

Multivariate analyses

Purpose

Track quarterly changes in
Provide estimates of quality,
selected quality, utilization, and utilization, and cost measures on
cost measures over the course of an annual basis.
the demonstration.

Measure changes in quality,
utilization, and cost measures
as a result of the
demonstration.

Description
of analysis

Comparison of current value and Comparison of the baseline
values over time to the baseline period with each demonstration
period for each outcome.
year for demonstration and
comparison groups.

Difference-in-differences
analyses using demonstration
and comparison groups.

Reporting
frequency

Quarterly to CMS and the
Commonwealth

Once, in the final evaluation
except for costs, which will
also be calculated (at least)
once prior to the final
evaluation.

Annually

NOTE: The reports to be submitted to CMS will include the qualitative data described earlier in this report in
addition to the quantitative data outlined here.

4.3.1 Monitoring Analysis
Data from Medicare fee for service (FFS) and Medicare Advantage encounter data, One
Care plan encounter data, MSIS files, and other data provided by Massachusetts via the State
Data Reporting System will be analyzed quarterly to calculate means, counts, and proportions on
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selected quality, utilization, and cost measures common across States, depending on availability.
Examples of measures that may be included in these quarterly reports to CMS include rates of
inpatient admissions, emergency room visits, long-term nursing facility admissions, cost per
member per month, and all-cause hospital readmission and mortality. We will present the current
value for each quarter and the predemonstration period value for each outcome to look at trends
over time.
The goal of these analyses is to monitor and track changes in quality, utilization, and
costs. Though quarterly analyses will not be multivariate or include comparison group data, these
monitoring data will provide valuable, ongoing information on trends occurring during the
demonstration period. Various inpatient and emergency room measures that can be reported are
described in more detail in the section on quality measures.

4.3.2 Descriptive Analysis on Quality, Utilization, and Cost Measures
We will conduct a descriptive analysis of quality, utilization, and cost measures for the
Massachusetts demonstration annually for each performance period that includes means, counts,
and proportions for the demonstration and comparison groups. This analysis will focus on
estimates for a broad range of quality, utilization, and cost measures, as well as changes in these
measures across years or subgroups of interest within each year. The results of these analyses
will be presented in the annual evaluation reports. The sections below outline the measures that
will be included.
To perform this analysis, we will develop separate (unlinked) encounter, Medicare, and
Medicaid beneficiary-level analytic files annually to measure quality, utilization, and cost.
Although the Medicare, Medicaid, and encounter data will not be linked, the unlinked
beneficiary-level files will still allow for an understanding of trends in quality, utilization, and
cost measures. The analytic files will include data from the predemonstration period and for each
demonstration year. Because of the longer expected time lags in the availability of Medicaid
data, Medicare fee-for-service data and One Care plan encounter data may be available sooner
than Medicaid fee-for-service data. Therefore, we expect that the first annual report will include
predemonstration Medicare and Medicaid fee-for-service data and Medicare fee-for-service,
Medicare Advantage, and One Care plan encounter data for the demonstration period. Medicaid
fee-for-service data will be incorporated into later reports as the data become available.
Consistent with the intent-to-treat approach, all individuals eligible to participate in the
demonstration will be included in the analysis, regardless of whether they opt out of the
demonstration or disenroll, or actively engage in the care model. Data will be developed for
demonstration and comparison group beneficiaries for a 2-year predemonstration period and for
each of the years of the demonstration. The starting date for Massachusetts will be based on the
Commonwealth’s implementation date and, therefore, may represent a “performance period,” not
necessarily a calendar year. Because the Commonwealth plans to phase in enrollment first for
those who actively select a One Care plan and later for those who are passively enrolled,
enrollment for those who are passively enrolled later in the year will be identified by setting a
dummy variable flag so that the analysis can determine whether the experience of those who
passively enroll differs from that of those who actively enroll. For those beneficiaries with
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shorter enrollment periods, because of beneficiary death or change of residence, for example, the
analysis will weight their experience by months of enrollment within a performance period.
We will measure predemonstration and annual utilization rates and costs of Medicareand Medicaid-covered services together, where appropriate, to look at trends in the type and
level of service use during the State demonstrations. We will calculate average use rates for each
demonstration period. Use rates will be stratified by hierarchical condition category (HCC)
scores, which are derived from models predicting annual Medicare spending based on claimbased diagnoses in a prior year of claims where higher scores are predictive of higher spending,
health status measures, or similar measures. We will adjust for hospitalizations in the prior year
using categorical HCC scores or similar. Chi-square and t-tests will be used to test for significant
differences in use across years and between subpopulations such as Medicare-Medicaid enrollees
using behavioral health services and those referred for long-term care services.

4.3.3 Multivariate Analyses of Quality, Utilization, and Cost Measures
In the final year of the evaluation, we will use data collected for the eligible population in
Massachusetts and data for the selected comparison group that will have been adjusted using
propensity-score weighting methods to analyze the effect of the demonstration using a
difference-in-differences method. This method uses both pre- and postperiod data for both the
demonstration and comparison groups to estimate effects. This method will be applied to these
data for each quality, utilization, and cost outcome described in the next section for the final
evaluation. The analytic approaches are described in greater detail in the Aggregate Evaluation
Plan (Walsh et al., 2013). In addition, multivariate regression-adjusted estimates of cost effects
(only) will be performed at an intermediate point of the evaluation, using data after 2 years of
implementation.

4.3.4 Subpopulation Analyses
Specific to the Massachusetts demonstration model, individuals with End Stage Renal
Disease (ESRD), people receiving behavioral health services, and people receiving long-term
services and supports (including individuals with developmental disabilities in the community
not receiving waiver services) are subpopulations of interest for this evaluation. Individuals with
chronic physical conditions, which the Commonwealth estimates to be about 40 percent of the
eligible population, are another major subpopulation for the demonstration evaluation. Other
subpopulations of potential interest to the evaluation may be identified to correspond to rating
categories for payments to One Care plans for people (1) with facility-based care; (2) high
community needs based on activities of daily living (ADL) needs, as determined from a
Minimum Data Set-Home Care (MDS-HC) assessment, if data are available electronically; or
(3) community high behavioral health needs. RTI will compare the characteristics of those who
enroll with those who are eligible but do not enroll in the care model and conduct analyses to
further explore demonstration effects on demonstration enrollees, acknowledging that selection
bias must be taken into account in interpreting the results.
For these subpopulations and others, RTI will evaluate the impact of the demonstration
on quality, utilization, and access to care for medical, LTSS, and behavioral health services, and
also examine qualitative data gathered through interviews, focus groups, and surveys.
Descriptive analyses for annual reports will present results on selected measures stratified by
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subpopulations (e.g., those using and not using behavioral health services, LTSS). Multivariate
analyses performed for the final evaluation will account for differential effects for
subpopulations in specification testing by using dummy variables for each of the specific
subpopulations of interest one at a time so that the analyses can suggest whether quality,
utilization, and cost are higher or lower for each of these groups.

4.4

Utilization and Access to Care

Medicare, Medicaid, and One Care plan encounter data will be used to evaluate changes
in the levels and types of services used, ranging along a continuum from institutional care to care
provided at home (Table 15). In addition to the services shown in Table 15, the Massachusetts
analysis will include a specific focus on mental health and substance use disorder prevention and
treatment services and community support services that will be expanded under the
demonstration. Expanded services that will be available in the Massachusetts demonstration that
may be tracked over time include dental, vision, and nonmedical transportation. As noted, two
services (but not the people receiving them) are excluded from the Massachusetts demonstration:
Department of Mental Health (DMH)– and Department of Developmental Services (DDS)–
provided targeted case management services, and DMH-purchased Rehabilitation Option
services. Note that Table 15 indicates the sources of data for these analyses during the
demonstration, given that the analyses will include beneficiaries who enroll in the demonstration
as well as those who are part of the population eligible for the demonstration, but do not enroll in
the demonstration.
Table 15
Service categories and associated data sources for reporting utilization measures

Service type

Encounter data
(Medicare Advantage,
One Care plans, and Medicaid only
Medicaid MCOs)
(FFS)

Medicare and
Medicaid
(FFS)

Inpatient

X

—

X

Emergency room

X

—

X

Nursing facility (short rehabilitation stay)

X

—

X

Nursing facility (long-term stay)

X

X

—

1

X

—

X

Outpatient2

X

—

X

Outpatient behavioral health (mental and
substance use)

X

X

—

Home health

X

—

X

HCBS (PAS, waiver services)

X

X

—

Dental

X

X

—

Other facility-based

— = not available; FFS = fee for service; HCBS = home and community-based services; MCO = managed care
organization; PAS = personal assistance services.
1
2

Includes long-term care hospital, rehabilitation hospital, State mental health facility stays.
Includes visits to physician offices, hospital outpatient departments, rehabilitation agencies.
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We anticipate being able to develop traditional utilization measures for each of the
service classes in Table 15 (e.g., various inpatient use rates based on diagnoses of interest);
however, as of this writing, the data that demonstration One Care plans will be required to
submit have not been finalized.

4.5

Quality of Care

Across all States, we will evaluate a core quality measure set for monitoring and
evaluation purposes. There are multiple data sources for quality measures: claims and encounter
data, which will be obtained and analyzed by the RTI team for evaluation measures listed in
Table 16; and information collected by the Commonwealth, CMS, or others and provided in
aggregate to the RTI team for inclusion in reports. The latter may include Health Care
Effectiveness Data and Information Set (HEDIS) measures collected as part of health plan
performance, other data Massachusetts requires its One Care plans to report, and any beneficiary
survey data collected by Massachusetts, CMS, or other entities (e.g., CAHPS). CMS and
Massachusetts have also identified a set of quality measures that will determine the amount of
quality withhold payments (i.e., One Care plans must meet quality standards to earn back a
withheld portion of their capitated payments). The quality withhold measures, listed in the
Massachusetts MOU, include some measures noted in this report, as well as additional measures.
RTI expects to have access to the aggregated results of these additional measures and will
include them in the evaluation as feasible and appropriate, understanding that these data are not
available for the pre-demonstration period or for the comparison group.
RTI and CMS have developed the core set of evaluation measures for use across State
demonstrations; the evaluation will also include a few measures specific to Massachusetts.
Table 16 provides a working list of the core quality measures for the evaluation of the financial
alignment initiative. The table specifies the measure, the source of data for the measure, whether
the measure is intended to produce impact estimates, as well as a more detailed definition and
specification of the numerator and denominator for the measure. These measures will be
supplemented by additional evaluation measures appropriate to the Massachusetts demonstration.
We will finalize State-specific quality measures within the first 6 months of implementation,
Many of the measures in Table 16 are established HEDIS measures that demonstration
plans are required to report. The National Committee for Quality Assurance (NCQA) definitions
are established and standardized. Given that these data will not be available for those who opt
out or disenroll or for comparison populations, we will collect and present the results for each
relevant demonstration period.
The unique features of Massachusetts’s planned demonstration suggest areas of special
focus in quality of care analyses. Notably, the new One Care plans will serve only those aged 21
to 64 at the time of enrollment (allowing those who turn 65 after enrollment to remain in the
demonstration). We have considered the value of collecting quality measures that have been
developed specifically for the over-65 population in the context of the younger age groups
eligible for the Massachusetts demonstration. We have decided to include measures such as
medication reconciliation and pneumonia vaccination, though they were developed for the over65 population. In the case of pneumonia vaccine, for example, the Centers for Disease Control
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and Prevention (CDC) has recommended that those aged 2 to 64 receive the vaccine if they have
long-term health problems.
Our analyses will pay particular attention to the types of care with the most change. The
Massachusetts demonstration plans to change the behavioral health system for enrollees by
making available a wide array of new services aimed at reducing the rate of acute psychiatric
hospitalization through the use of “diversionary” services. Thus, although the generic measures
of quality include all-cause readmission rates, and ambulatory care sensitive conditions (ACSC)
hospitalization rates, our evaluation of the Massachusetts demonstration will also examine rates
of hospitalization with primary diagnosis of a severe and persistent mental illness or substance
use disorder. Another measure of relevance to Massachusetts given the increase in mental health
benefits during the demonstration may be a National Quality Forum (NQF) measure of initiation
and engagement of alcohol and other drug dependence treatment. This measure looks at the
initiation of treatment and subsequent service use within 30 days of initiating treatment and can
be calculated using claims and encounter data.
Finally, the evaluation will analyze subgroups of interest, as appropriate, and look at
measures that might be particularly relevant to them (e.g., measures that might be specific to
people with developmental disabilities, behavioral health conditions). We will continue to work
with CMS and the Commonwealth to identify measures relevant to Massachusetts and will work
to develop specifications for these measures.
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Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description

Care
coordination

Yes

Risk-adjusted percentage of demonstrationeligible Medicare-Medicaid enrollees who
were readmitted to a hospital within 30 days
following discharge from the hospital for the
index admission
(https://www.cms.gov/sharedsavingsprogram/
Downloads/ACO_QualityMeasures.pdf).

Numerator: Risk-adjusted readmissions among
demonstration-eligible Medicare-Medicaid enrollees
at a non-Federal, short-stay, acute-care or critical
access hospital, within 30 days of discharge from the
index admission included in the denominator, and
excluding planned readmissions.
Denominator: All hospitalizations among
demonstration-eligible Medicare-Medicaid enrollees
not related to medical treatment of cancer, primary
psychiatric disease, or rehabilitation care, fitting of
prostheses, and adjustment devices for beneficiaries
at non-Federal, short-stay acute-care or critical
access hospitals, where the beneficiary was
continuously enrolled in Medicare and Medicaid for
at least 1 month after discharge, was not discharged
to another acute-care hospital, was not discharged
against medical advice, and was alive upon
discharge and for 30 days postdischarge.

Immunizations
Influenza
immunization

Prevention

Yes

Percentage of demonstration-eligible
Medicare-Medicaid enrollees seen for a visit
between October 1 and March 31 of the 1year measurement period who received an
influenza immunization OR who reported
previous receipt of an influenza immunization
(https://www.cms.gov/sharedsavingsprogram/
Downloads/ACO_QualityMeasures.pdf).

Numerator: Demonstration-eligible MedicareMedicaid enrollees who have received an influenza
immunization OR who reported previous receipt of
influenza immunization.
Denominator: Demonstration-eligible MedicareMedicaid enrollees seen for a visit between October
1 and March 31 (flu season), with some exclusions
allowed.
(continued)

Claims/encounter
RTI will acquire
and analyze
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Claims/encounter
All-cause
readmission
RTI will acquire
30-day all-cause and analyze
risk-standardized
readmission rate
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Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description
Numerator: Demonstration-eligible Medicare-Medicaid
enrollees under age 65who have ever received a
pneumococcal vaccination.
Denominator: All demonstration-eligible MedicareMedicaid enrollees under age 65, excluding those with
documented reason for not having one.

Ambulatory care- Claims/encounter Prevention, care Yes
sensitive condition RTI will acquire coordination
admission
and analyze
Ambulatory care
sensitive condition
admissions—
overall composite
(AHRQ PQI # 90)

Combination using 12 individual ACSC
diagnoses for chronic and acute
conditions. For technical specifications of
each diagnosis, see
http://www.qualityindicators.ahrq.gov/M
odules/PQI_TechSpec.aspx.

Numerator: Total number of acute-care hospitalizations
for 12 ambulatory care-sensitive conditions among
demonstration-eligible Medicare-Medicaid enrollees,
aged 18 or older. Conditions include diabetes—shortterm complications; diabetes—long-term
complications; COPD; hypertension; CHF;
dehydration; bacterial pneumonia; UTI; angina without
procedure; uncontrolled diabetes; adult asthma; lower
extremity amputations among diabetics.
Denominator: Demonstration-eligible MedicareMedicaid enrollees, aged 18 or older.

Claims/encounter Prevention, care Yes
RTI will acquire coordination
and analyze

Combination using 9 individual ACSC
diagnoses for chronic diseases. For
technical specifications of each diagnosis,
see
http://www.qualityindicators.ahrq.gov/M
odules/PQI_TechSpec.aspx.

Numerator: Total number of acute-care hospitalizations
for 9 ambulatory care sensitive chronic conditions
among demonstration-eligible Medicare-Medicaid
enrollees, aged 18 or older. Conditions include
diabetes—short-term complications; diabetes—longterm complications; COPD; hypertension; CHF; angina
w/o procedure; uncontrolled diabetes; adult asthma;
lower-extremity amputations among diabetics).
Denominator: demonstration-eligible MedicareMedicaid enrollees, aged 18 or older.
(continued)

Ambulatory caresensitive condition
admissions—
chronic composite
(AHRQ PQI # 92)

Claims/encounter Prevention
RTI will acquire
and analyze

Yes
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Percentage of demonstration-eligible
patients under age 65who have ever
received a pneumococcal vaccine.

Immunizations
(cont'd)
Pneumococcal
vaccination for
patients under age
65
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description

Prevention, care Yes
coordination

Percentage of demonstration-eligible
Medicare-Medicaid enrollees with a
primary diagnosis of a severe and
persistent mental illness or substance use
disorder who are hospitalized

Numerator: Total number of acute-care hospitalizations
among demonstration-eligible Medicare-Medicaid
enrollees, aged 18 or older with a primary diagnosis of
a severe and persistent mental illness or substance use
who are hospitalized.
Denominator: Demonstration-eligible MedicareMedicaid enrollees, aged 18 or older.

Claims/encounter
Avoidable
emergency
RTI will acquire
department visits and analyze
Preventable/
avoidable and
primary care
treatable ED visits

Prevention, care Yes
coordination

Based on lists of diagnoses developed by
researchers at the New York University
Center for Health and Public Service
Research, this measure calculates the rate
of ED use for conditions that are either
preventable/avoidable, or treatable in a
primary care setting
(http://wagner.nyu.edu/faculty/billings/
nyued-background).

Numerator: Total number of ED visits with principal
diagnoses defined in the NYU algorithm among
demonstration-eligible Medicare-Medicaid enrollees.
Denominator: Demonstration-eligible MedicareMedicaid enrollees.

Claims/encounter
Emergency
department visits RTI will acquire
ED visits
and analyze
excluding those
that result in death
or hospital
admission

Prevention, care Yes
coordination

Percentage of demonstration-eligible
Medicare-Medicaid enrollees with an
emergency department visit.

Numerator: Total number of ED visits among
demonstration-eligible Medicare-Medicaid enrollees
excluding those that result in death or hospital
admission.
Denominator: Demonstration-eligible MedicareMedicaid enrollees.
(continued)

51

4. Impact and Outcomes

Claims/encounter
RTI will acquire
and analyze

Admissions with
primary diagnosis
of a severe and
persistent mental
illness or
substance use
disorder
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description

Claims/encounter Care
RTI will acquire coordination
and analyze

Yes

Percentage of discharges for
demonstration-eligible MedicareMedicaid enrollees who were
hospitalized for selected mental health
disorders and who had an outpatient
visit, an intensive outpatient encounter,
or partial hospitalization with a mental
health practitioner. Two rates are
reported: (1) The percentage of members
who received follow-up within 30 days
of discharge; (2) The percentage of
members who received follow-up within
7 days of discharge
(http://www.qualityforum.org/QPS/).

Numerator: Rate 1: (Among demonstration-eligible
Medicare-Medicaid enrollees) an outpatient visit,
intensive outpatient encounter, or partial hospitalization
with a mental health practitioner within 30 days after
discharge. Include outpatient visits, intensive outpatient
encounters, or partial hospitalizations that occur on the
date of discharge; Rate 2: (Among demonstrationeligible Medicare-Medicaid enrollees) an outpatient
visit, intensive outpatient encounter, or partial
hospitalization with a mental health practitioner within
7 days after discharge. Include outpatient visits,
intensive outpatient encounters, or partial
hospitalizations that occur on the date of discharge.
Denominator: demonstration-eligible MedicareMedicaid enrollees who were discharged alive from an
acute inpatient setting (including acute-care psychiatric
facilities) in the measurement year. The denominator
for this measure is based on discharges, not members.
Include all discharges for members who have more than
one discharge in the measurement year.

Fall prevention
Screening for Fall
Risk

Claims/encounter Prevention, care Yes
RTI will acquire coordination
and analyze if
available

Percentage of demonstration-eligible
Medicare-Medicaid enrollees under age
65 who were screened for future fall risk
at least once within 12 months

Numerator: Demonstration-eligible Medicare-Medicaid
enrollees who were screened for future fall risk at least
once within 12 months.
Denominator: All demonstration-eligible MedicareMedicaid enrollees under age 65.
(continued)
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Follow-up after
mental health
hospitalization
Follow-up after
hospitalization for
mental illness
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

MDS
RTI will acquire
and analyze

Definition
(link to documentation if available)

Numerator/denominator description

Percentage of demonstration-eligible
beneficiaries evaluated in an outpatient
setting who within the past 12 months
have experienced AMI, CABG surgery,
PCI, CVA, or cardiac transplantation, or
who have CVA and have not already
participated in an early outpatient CR
program for the qualifying event/
diagnosis who were referred to a CR
program.

Numerator: Number of demonstration-eligible
Medicare-Medicaid enrollees in an outpatient practice
who have had a qualifying event/diagnosis in the
previous 12 months who have been referred to an
outpatient cardiac rehabilitation/secondary prevention
program.
Denominator: Number of demonstration-eligible
Medicare-Medicaid enrollees in an outpatient clinical
practice who have had a qualifying cardiovascular event
in the previous 12 months, who do not meet any of the
exclusion criteria, and who have not participated in an
outpatient cardiac rehabilitation program since the
cardiovascular event.

Prevention, care Yes
coordination

Percentage of all demonstration-eligible
long-stay residents in a nursing facility
with an annual, quarterly, significant
change, or significant correction MDS
assessment during the selected quarter
(3-month period) who were identified as
high risk and who have one or more
Stage 2–4 pressure ulcer(s).

Numerators: Number of demonstration-eligible
Medicare-Medicaid enrollees who are long-stay nursing
facility residents who have been assessed with annual,
quarterly, significant change, or significant correction
MDS 3.0 assessments during the selected time window
and who are defined as high risk with one or more
Stage 2–4 pressure ulcer(s).
Denominators: Number of demonstration-eligible
Medicare-Medicaid enrollees who are long-stay
residents who received an annual, quarterly, or
significant change or significant correction assessment
during the target quarter and who did not meet
exclusion criteria.
(continued)
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Yes

Claims/encounter Care
Cardiac
rehabilitation
RTI will acquire coordination
Cardiac
and analyze
rehabilitation
following
hospitalization for
AMI, angina
CABG, PCI, CVA

Pressure ulcers
Percent of highrisk residents with
pressure ulcers
(long stay)

Will evaluation
produce impact
estimates?1
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Claims/encounter Care
Treatment of
alcohol and
RTI will acquire coordination
substance use
and analyze
disorders
Initiation and
Engagement of
Alcohol and Other
Drug Dependence
Treatment

Will evaluation
produce impact
estimates?1
Yes

Definition
(link to documentation if available)
The percentage of demonstration-eligible
Medicare-Medicaid enrollees with a new
episode of alcohol or other drug (AOD)
dependence who received the following:
a. Initiation of AOD Treatment. The
percentage who initiate treatment
through an inpatient AOD admission,
outpatient visit, intensive outpatient
encounter or partial hospitalization
within 14 days of the diagnosis.
b. Engagement of AOD Treatment. The
percentage who initiated treatment and
who had two or more additional services
with a diagnosis of AOD within 30 days
of the initiation visit.
(http://www.qualityforum.org/QPS/)

Numerator/denominator description
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Numerator: Among demonstration-eligible MedicareMedicaid enrollees (a) Initiation: AOD treatment
through an inpatient admission, outpatient visit,
intensive outpatient encounter or partial hospitalization
within 14 days of diagnosis; (b) Engagement: AOD
treatment and two or more inpatient admissions,
outpatient visits, intensive outpatient encounters or
partial hospitalizations with any AOD diagnosis within
30 days after the date of the Initiation encounter
(inclusive). Multiple engagement visits may occur on
the same day, but they must be with different providers
in order to be counted. Do not count engagement
encounters that include detoxification codes (including
inpatient detoxification)
Denominator: Demonstration-eligible MedicareMedicaid enrollees age 13 years and older who were
diagnosed with a new episode of alcohol and drug
dependency during the intake period of January 1–
November 15 of the measurement year.
EXCLUSIONS: Exclude those who had a
claim/encounter with a diagnosis of AOD during the 60
days before the IESD. For an inpatient IESD, use the
admission date to determine the Negative Diagnosis
History. For an ED visit that results in an inpatient stay,
use the ED date of service.
(continued)
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description

Depression
screening and
follow-up
Screening for
clinical depression
and follow-up

Claims/encounter Prevention, care No
RTI will acquire coordination
and analyze if
available

Percentage of patients aged 18 and older
screened for clinical depression using an
age-appropriate standardized tool AND
follow-up plan documented
(http://www.cms.gov/Regulations-andGuidance/Legislation/EHRIncentiveProg
rams/Downloads/2014_eCQM_EP_June
2013.zip).

Numerator: Demonstration-eligible Medicare-Medicaid
enrollees whose screening for clinical depression using
an age-appropriate standardized tool AND follow-up
plan is documented.
Denominator: All demonstration-eligible MedicareMedicaid enrollees 18 years and older with certain
exceptions (see source for the list).

Blood pressure
control
Controlling high
blood pressure

Medical records
(HEDIS
EOC035)

Prevention, care No
coordination

Percentage of members aged 18–85 who
had a diagnosis of hypertension and
whose blood pressure was adequately
controlled (<140/90) during the
measurement year
(http://www.qualityforum.org/QPS).

Numerator: Number of demonstration participants in
the denominator whose most recent, representative BP
is adequately controlled during the measurement year.
For a member’s BP to be controlled, both the systolic
and diastolic BP must be <140/90mm Hg.
Denominator: Demonstration participants with
hypertension. A patient is considered hypertensive if
there is at least one outpatient encounter with a
diagnosis of HTN during the first 6 months of the
measurement year.

Weight screening
and follow-up
Adult BMI
assessment

Medical records
(HEDIS
EOC110)

Prevention

Percentage of patients aged 18–74 years
of age who had an outpatient visit and
who had their BMI documented during
the measurement year or the year prior to
measurement.

Numerator: BMI documented during the measurement
year, or the year prior.
Denominator: Demonstration-eligible MedicareMedicaid enrollees 18–74 who had an outpatient visit.

No

55

4. Impact and Outcomes

(continued)

Measurement, Monitoring, and Evaluation of State
Demonstrations to Integrate Care for Dual Eligible Individuals

Massachusetts Evaluation Design Plan — December 23, 2013

Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)

Data sources
and
responsibility
for data
collection

Domain
(prevention,
care
coordination,
beneficiary
experience)

Will evaluation
produce impact
estimates?1

Definition
(link to documentation if available)

Numerator/denominator description

Breast cancer
screening

Medical records
(HEDIS 0003)

Prevention

No

Percentage of women 40–69 years of age
and participating in demonstration who
had a mammogram to screen for breast
cancer.

Numerator: Number of women 40–69 receiving
mammogram in year.
Denominator: Number of women 40–69 enrolled in
demonstration.

Antidepressant
medication
management

Medical records
(HEDIS
EOC030)

Care
coordination

No

Percentage of members 18+ who were
diagnosed with a new episode of major
depression and treated with antidepressant
medication, and who remained on an
antidepressant medication treatment.

Numerator: Two rates are reported. (1) Effective acute
phase treatment—newly diagnosed and treated
demonstration participants who remain on
antidepressant medication for at least 84 days.
(2) Effective continuation phase treatment—newly
diagnosed and treated demonstration participants who
remained on antidepressant medication for at least 180
days.
Denominator: Newly diagnosed and treated
demonstration participants over age 18.

Diabetes care
Comprehensive
diabetes care:
selected
components—
HbA1c control,
LDL-C control,
retinal eye exam

Medical records
(HEDIS
EOC020)

Prevention/care
coordination

No

Percentage of demonstration participants
18–75 years of age with diabetes (type 1
and type 2) who had each of the
following: HbA1c control, LDL-C control,
and retinal eye exam.

Numerator: Number of these who had HbA1c control
or LDL-C control, or retinal eye exam in year.
Denominator: Demonstration participants 18–75 with
type 1 or type 2 diabetes.
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

Measure
concept
(specific
measure)
Medication
management
Annual
monitoring for
patients on
persistent
medications

Data sources
and
responsibility
for data
collection
Medical records
(HEDIS
EOC075)

Domain
(prevention,
care
coordination,
beneficiary
experience)
Care
coordination

Will evaluation
produce impact
estimates?1
No

Definition
(link to documentation if available)
Percentage who received at least 180
treatment days of ambulatory medication
therapy for a select therapeutic agent
during the measurement year and at least
one therapeutic monitoring event for the
therapeutic agent in the measurement year.
Agents measured: (1) ACE inhibitors or
ARB, (2) digoxin, (3) diuretics,
(4) anticonvulsants.

Numerator/denominator description
Numerator: Number with at least 180 days of
treatment AND a monitoring event in the
measurement year. Combined rate is sum of 4
numerators divided by sum of 4 denominators.
Denominator: Demonstration participants with at least
180 days of treatment in the year for a particular
agent.

ACE = angiotensin-converting-enzyme; ACSC = ambulatory care-sensitive conditions; AMI = acute myocardial infarction; AOD = alcohol or other drug; ARB = angiotensin II
receptor blockers; BMI = body mass index; BP = blood pressure; CABG = coronary artery bypass graft; CHF = congestive heart failure; COPD = chronic obstructive pulmonary
disease; CVA= cerebrovascular accident; ED = emergency department; HbA1c = Hemoglobin A1C; HEDIS = Healthcare Effectiveness Data and Information Set; HTN =
hypertension; IESD = Index Episode Start Date; LDL-C = low-density-lipoprotein cholesterol (bad cholesterol); MDS = minimum data set; PCI = percutaneous coronary
intervention; UTI = urinary tract infection.
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Table 16 (continued)
Evaluation quality measures: Detailed definitions, use, and specifications

1

Impact estimates will be produced only for measures where data can also be obtained for the comparison group. Measures for which data are not expected to be available in the
comparison group will be tracked only within the demonstration to measures changes over time.
NOTE: Definitions, use, and specifications are as of 12/23/2013.
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Cost

To determine annual total costs (overall and by payer), we will aggregate the Medicare
and Medicaid per member per month (PMPM) payments paid to the One Care plans and the
costs for the eligible population who are not enrolled in the demonstration, per the intent to treat
evaluation design. This approach will help us to detect overall cost impact and eliminate the
effects of potential selection bias among beneficiaries who participate in the demonstration and
those who opt out or disenroll. We will include Part D PMPM and any PMPM reconciliation
data provided by CMS in the final assessment of cost impact to ensure that all data are available.
The evaluation will analyze cost data for the service types shown in Table 14 in the
previous section on utilization with the addition of prescription drug costs. We will present
results for important subgroups, and in more detail to better understand their demonstration
experience. We will also create a high-cost-user category and track costs of this group over time.
To do this, we will measure the percentage of beneficiaries defined as high cost in Year 1 (e.g.,
those beneficiaries in the top 10 percent of costs). In subsequent years we will look at the
percentage of beneficiaries above the Year 1 threshold to learn more about potential success in
managing the costs of high-cost beneficiaries as a result of the demonstration.
We will also evaluate cost savings for capitated model demonstrations twice during the
demonstration, using a regression-based approach and the comparison group described in
Section 4.2.2 of this report. The methodology for evaluating cost savings for capitated model
demonstrations is currently under development and will be reviewed and approved by the CMS
Office of the Actuary. We will also estimate cost savings accruing to the Medicare and Medicaid
programs separately.

4.7

Analytic Challenges

Obtaining Medicaid fee-for-service data for the predemonstration and demonstration
periods and One Care plan encounter data for the demonstration period will be critical for the
evaluation. It will be important for Massachusetts to submit Medicaid fee-for-service data in a
timely manner. It will also be important for CMS to continue to work with other States that may
serve as comparison groups to update and maintain their MSIS/t-MSIS submissions.
Additionally, in order to identify costs by service category, encounter data need to include
pricing information. One Care plan encounter data are in the process of being finalized, so RTI
will continue to work closely with CMS to understand the contents of the data provided by plans
and how best these data can be utilized by the evaluation.

Massachusetts Evaluation Design Plan — December 23, 2013

58

5. References
Centers for Medicare & Medicaid Services (CMS): Personal communication, May 29, 2013.
Centers for Medicare & Medicaid Services (CMS): Medicare-Medicaid Capitated Financial
Alignment Model Reporting Requirements. November 25, 2013.
http://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-MedicaidCoordination/Medicare-Medicaid-CoordinationOffice/FinancialAlignmentInitiative/Downloads/FinalCY2014CoreReportingRequirements.pdf.
As obtained December 9, 2013.
Centers for Medicare & Medicaid Services (CMS) and the Commonwealth of Massachusetts:
Memorandum of Understanding Regarding a Federal-State Partnership to Test a Capitated
Financial Alignment Model for Medicare-Medicaid Enrollees.
http://www.mass.gov/eohhs/docs/eohhs/healthcare-reform/state-fed-comm/120822-duals-demomou.pdf. August 22, 2012.
Commonwealth of Massachusetts, Executive Office of Health and Human Services. Office of
Medicaid. Boston, MA. Direct communication, September 4, 2013.
Commonwealth of Massachusetts, Executive Office of Health and Human Services, Office of
Medicaid: State demonstration to integrate care for Medicare-Medicaid enrollees: Proposal to the
Center for Medicare and Medicaid Innovation. February 16, 2012. .Boston, MA. Office of
Medicaid, the Commonwealth of Massachusetts. http://www.cms.gov/Medicare-MedicaidCoordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-CoordinationOffice/Downloads/MassachusettsProposal.pdf. 2012a.
Commonwealth of Massachusetts, Executive Office of Health and Human Services, Office of
Medicaid: Addendum to State demonstration to integrate care for Medicare-Medicaid enrollees:
Proposal to the Center for Medicare and Medicaid Innovation. August 23, 2012. Boston, MA.
Office of Medicaid, the Commonwealth of Massachusetts.
http://www.mass.gov/eohhs/docs/eohhs/healthcare-reform/state-fed-comm/120822-duals-demomou-addendum.pdf. 2012b.
Commonwealth of Massachusetts, Executive Office of Health and Human Services, and United
States Department of Health and Human Services Centers for Medicare & Medicaid Services
Center for Medicare and Medicaid Innovation: Request for Responses from Integrated Care
Organizations. (RFR #12 CBEHSDUALSICORFR) Issued June 18, 2012.
http://www.mass.gov/eohhs/docs/eohhs/healthcare-reform/120730-duals-demo-rfr.pdf. 2012c.
As obtained July 9, 2012.
Lind, A., and Gore, S.: From the Beneficiary Perspective: Core Elements to Guide Integrated
Care for Dual Eligibles. Hamilton, NJ. Center for Health Care Strategies, 2010.
Walsh, E. G., Anderson, W., Greene, A., et al.: Measurement, Monitoring, and Evaluation of
State Demonstrations to Integrate Care for Dual Eligible Individuals: Aggregate Evaluation Plan.
Contract No. HHSM500201000021i TO #3. Waltham, MA. RTI International, December 16,
2013.

Massachusetts Evaluation Design Plan — December 23, 2013

59

